| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-1 | 603 | 2025 | 961 | 36.510 |
Why?
|
| Receptors, Interleukin-1 | 132 | 2024 | 214 | 12.070 |
Why?
|
| Interleukin-18 | 118 | 2024 | 235 | 11.790 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 153 | 2024 | 254 | 9.440 |
Why?
|
| Inflammation | 177 | 2025 | 2880 | 9.410 |
Why?
|
| Interleukin-1beta | 82 | 2024 | 395 | 9.310 |
Why?
|
| Cytokines | 197 | 2024 | 2065 | 9.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 245 | 2023 | 1217 | 8.260 |
Why?
|
| Interleukins | 69 | 2023 | 248 | 7.420 |
Why?
|
| Anti-Inflammatory Agents | 41 | 2023 | 475 | 5.790 |
Why?
|
| Sialoglycoproteins | 96 | 2005 | 158 | 5.230 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 33 | 2026 | 169 | 4.810 |
Why?
|
| Leukocytes, Mononuclear | 109 | 2021 | 573 | 4.780 |
Why?
|
| Interleukin-1alpha | 28 | 2021 | 57 | 4.320 |
Why?
|
| Immunity, Innate | 44 | 2025 | 846 | 4.310 |
Why?
|
| Interleukin-6 | 92 | 2025 | 780 | 4.260 |
Why?
|
| Lipopolysaccharides | 136 | 2024 | 863 | 4.150 |
Why?
|
| Inflammasomes | 27 | 2024 | 146 | 4.120 |
Why?
|
| Monocytes | 106 | 2024 | 538 | 4.060 |
Why?
|
| Interferon-gamma | 87 | 2021 | 784 | 3.880 |
Why?
|
| Caspase 1 | 48 | 2018 | 148 | 3.610 |
Why?
|
| alpha 1-Antitrypsin | 22 | 2026 | 102 | 3.440 |
Why?
|
| Animals | 578 | 2026 | 38109 | 3.410 |
Why?
|
| Histone Deacetylase Inhibitors | 29 | 2019 | 220 | 3.270 |
Why?
|
| Antirheumatic Agents | 21 | 2016 | 304 | 3.120 |
Why?
|
| Mice | 317 | 2026 | 18365 | 2.900 |
Why?
|
| Recombinant Proteins | 147 | 2023 | 1371 | 2.750 |
Why?
|
| Autoimmune Diseases | 26 | 2019 | 463 | 2.660 |
Why?
|
| Fever | 66 | 2019 | 312 | 2.550 |
Why?
|
| Humans | 868 | 2026 | 144957 | 2.510 |
Why?
|
| Glycoproteins | 46 | 2006 | 355 | 2.450 |
Why?
|
| Inflammation Mediators | 34 | 2018 | 509 | 2.410 |
Why?
|
| Antibodies, Monoclonal | 32 | 2023 | 1524 | 2.370 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 49 | 2023 | 381 | 2.100 |
Why?
|
| Cells, Cultured | 152 | 2023 | 4155 | 2.080 |
Why?
|
| Hydroxamic Acids | 23 | 2018 | 94 | 2.070 |
Why?
|
| Colitis | 21 | 2022 | 280 | 2.070 |
Why?
|
| Macrophages | 77 | 2026 | 1511 | 2.070 |
Why?
|
| Neutrophils | 52 | 2021 | 1134 | 2.050 |
Why?
|
| Signal Transduction | 78 | 2025 | 5233 | 2.050 |
Why?
|
| Pyrogens | 54 | 2004 | 55 | 2.010 |
Why?
|
| Endotoxins | 58 | 2004 | 221 | 1.950 |
Why?
|
| Interleukin-8 | 38 | 2020 | 271 | 1.920 |
Why?
|
| Gene Expression Regulation | 62 | 2021 | 2609 | 1.910 |
Why?
|
| Mice, Inbred C57BL | 118 | 2026 | 5997 | 1.890 |
Why?
|
| Receptors, Immunologic | 36 | 2011 | 206 | 1.830 |
Why?
|
| Arthritis, Gouty | 7 | 2020 | 13 | 1.820 |
Why?
|
| Carrier Proteins | 22 | 2017 | 737 | 1.730 |
Why?
|
| Renal Dialysis | 34 | 2009 | 462 | 1.720 |
Why?
|
| Receptors, Interleukin | 16 | 2022 | 43 | 1.710 |
Why?
|
| Nitriles | 9 | 2023 | 205 | 1.620 |
Why?
|
| Arthritis, Experimental | 9 | 2019 | 141 | 1.490 |
Why?
|
| Melanoma | 12 | 2026 | 761 | 1.470 |
Why?
|
| Peritonitis | 7 | 2020 | 84 | 1.450 |
Why?
|
| Adaptive Immunity | 10 | 2019 | 169 | 1.420 |
Why?
|
| Interleukin-17 | 9 | 2020 | 118 | 1.420 |
Why?
|
| RNA, Messenger | 93 | 2022 | 2832 | 1.410 |
Why?
|
| Dinoprostone | 42 | 2007 | 178 | 1.390 |
Why?
|
| T-Lymphocytes | 63 | 2021 | 1982 | 1.330 |
Why?
|
| Receptors, Interleukin-18 | 14 | 2021 | 17 | 1.300 |
Why?
|
| Toll-Like Receptors | 16 | 2018 | 194 | 1.280 |
Why?
|
| Cell Line | 78 | 2021 | 2882 | 1.280 |
Why?
|
| Receptors, Interleukin-1 Type I | 9 | 2025 | 25 | 1.270 |
Why?
|
| Shock, Septic | 25 | 2016 | 216 | 1.250 |
Why?
|
| Uric Acid | 7 | 2021 | 166 | 1.250 |
Why?
|
| Mice, Transgenic | 41 | 2026 | 2185 | 1.240 |
Why?
|
| Mice, Knockout | 74 | 2026 | 3125 | 1.230 |
Why?
|
| Immune Tolerance | 11 | 2023 | 379 | 1.200 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 14 | 2016 | 14 | 1.200 |
Why?
|
| Rheumatic Diseases | 5 | 2019 | 97 | 1.180 |
Why?
|
| Candida albicans | 10 | 2024 | 61 | 1.170 |
Why?
|
| Receptors, Tumor Necrosis Factor | 26 | 2005 | 163 | 1.170 |
Why?
|
| Disease Models, Animal | 56 | 2026 | 4569 | 1.160 |
Why?
|
| NF-kappa B | 30 | 2024 | 662 | 1.140 |
Why?
|
| Interleukin-12 | 21 | 2018 | 117 | 1.140 |
Why?
|
| Sulfones | 13 | 2023 | 127 | 1.110 |
Why?
|
| Th1 Cells | 10 | 2013 | 139 | 1.100 |
Why?
|
| Autophagy | 6 | 2022 | 286 | 1.100 |
Why?
|
| Proteins | 46 | 2008 | 1022 | 1.090 |
Why?
|
| Recombinant Fusion Proteins | 17 | 2016 | 675 | 1.080 |
Why?
|
| Psoriasis | 6 | 2020 | 112 | 1.080 |
Why?
|
| Male | 308 | 2026 | 72406 | 1.080 |
Why?
|
| Interleukin-1 Receptor Accessory Protein | 6 | 2019 | 9 | 1.060 |
Why?
|
| Neoplasms | 30 | 2023 | 2884 | 1.050 |
Why?
|
| STAT3 Transcription Factor | 7 | 2023 | 207 | 1.030 |
Why?
|
| Arthritis, Rheumatoid | 23 | 2019 | 1169 | 1.030 |
Why?
|
| Lymphocyte Activation | 73 | 2021 | 1126 | 1.020 |
Why?
|
| Immunologic Factors | 5 | 2021 | 255 | 1.010 |
Why?
|
| B-Lymphocytes | 13 | 2025 | 877 | 0.970 |
Why?
|
| In Vitro Techniques | 71 | 2020 | 1048 | 0.970 |
Why?
|
| Biological Factors | 11 | 2019 | 39 | 0.970 |
Why?
|
| Melanoma, Experimental | 10 | 2021 | 108 | 0.970 |
Why?
|
| Graft vs Host Disease | 12 | 2018 | 264 | 0.930 |
Why?
|
| Interleukin-2 | 42 | 1999 | 437 | 0.930 |
Why?
|
| Killer Cells, Natural | 31 | 2018 | 469 | 0.930 |
Why?
|
| Immunity, Cellular | 7 | 2026 | 272 | 0.890 |
Why?
|
| Staphylococcus epidermidis | 16 | 2018 | 79 | 0.890 |
Why?
|
| Female | 253 | 2025 | 78376 | 0.880 |
Why?
|
| HIV-1 | 14 | 2013 | 896 | 0.850 |
Why?
|
| Body Temperature | 28 | 2012 | 229 | 0.840 |
Why?
|
| Endotoxemia | 10 | 2017 | 87 | 0.840 |
Why?
|
| Dendritic Cells | 14 | 2026 | 499 | 0.830 |
Why?
|
| Antibodies | 18 | 2017 | 403 | 0.830 |
Why?
|
| Kidney Failure, Chronic | 14 | 2009 | 598 | 0.820 |
Why?
|
| Protein Biosynthesis | 32 | 1998 | 458 | 0.820 |
Why?
|
| Receptors, Cell Surface | 16 | 2015 | 377 | 0.810 |
Why?
|
| Myeloid-Derived Suppressor Cells | 2 | 2021 | 72 | 0.800 |
Why?
|
| Myocardial Infarction | 11 | 2016 | 1209 | 0.800 |
Why?
|
| Histone Deacetylases | 14 | 2018 | 210 | 0.790 |
Why?
|
| Gene Expression | 41 | 2021 | 1490 | 0.780 |
Why?
|
| Protein Precursors | 12 | 2009 | 137 | 0.770 |
Why?
|
| Rabbits | 77 | 2005 | 648 | 0.770 |
Why?
|
| C-Reactive Protein | 18 | 2022 | 417 | 0.750 |
Why?
|
| Leukocytes | 31 | 2019 | 295 | 0.750 |
Why?
|
| Radioimmunoassay | 41 | 2003 | 165 | 0.740 |
Why?
|
| Cardiovascular Diseases | 7 | 2020 | 2171 | 0.730 |
Why?
|
| Escherichia coli | 35 | 2014 | 855 | 0.730 |
Why?
|
| Bacterial Toxins | 12 | 2002 | 110 | 0.720 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 10 | 2013 | 131 | 0.720 |
Why?
|
| Intestinal Mucosa | 9 | 2023 | 676 | 0.720 |
Why?
|
| Exercise Tolerance | 4 | 2019 | 283 | 0.720 |
Why?
|
| Membrane Glycoproteins | 13 | 2011 | 496 | 0.720 |
Why?
|
| Blood Cells | 6 | 2009 | 37 | 0.720 |
Why?
|
| Antineoplastic Agents | 15 | 2019 | 2197 | 0.710 |
Why?
|
| Sepsis | 19 | 2016 | 641 | 0.710 |
Why?
|
| Adult | 165 | 2025 | 40506 | 0.710 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2026 | 1129 | 0.710 |
Why?
|
| Granulomatous Disease, Chronic | 5 | 2017 | 48 | 0.700 |
Why?
|
| Interleukin-10 | 16 | 2019 | 310 | 0.700 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 210 | 0.690 |
Why?
|
| Antibodies, Neutralizing | 4 | 2021 | 341 | 0.680 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2022 | 365 | 0.680 |
Why?
|
| Vitiligo | 3 | 2016 | 42 | 0.680 |
Why?
|
| Neovascularization, Pathologic | 11 | 2013 | 286 | 0.670 |
Why?
|
| Dose-Response Relationship, Drug | 53 | 2015 | 2032 | 0.660 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 16 | 2015 | 266 | 0.660 |
Why?
|
| Antibodies, Monoclonal, Humanized | 11 | 2020 | 988 | 0.660 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 26 | 2022 | 851 | 0.650 |
Why?
|
| Biomarkers | 32 | 2022 | 4275 | 0.630 |
Why?
|
| Autoimmunity | 4 | 2019 | 927 | 0.630 |
Why?
|
| Heart Failure | 12 | 2021 | 2323 | 0.630 |
Why?
|
| Toll-Like Receptor 4 | 15 | 2017 | 276 | 0.620 |
Why?
|
| Cysteine Endopeptidases | 8 | 2003 | 73 | 0.620 |
Why?
|
| Protein Isoforms | 14 | 2015 | 402 | 0.620 |
Why?
|
| Endothelial Cells | 8 | 2021 | 870 | 0.620 |
Why?
|
| Enzyme Inhibitors | 16 | 2015 | 826 | 0.620 |
Why?
|
| Middle Aged | 124 | 2025 | 35928 | 0.620 |
Why?
|
| Hematopoiesis | 9 | 2019 | 194 | 0.620 |
Why?
|
| Adipose Tissue | 7 | 2018 | 653 | 0.610 |
Why?
|
| Receptors, Cytokine | 7 | 2019 | 36 | 0.610 |
Why?
|
| Antibodies, Blocking | 1 | 2019 | 37 | 0.610 |
Why?
|
| Transcription, Genetic | 28 | 2016 | 1496 | 0.600 |
Why?
|
| Atherosclerosis | 7 | 2017 | 409 | 0.590 |
Why?
|
| Arthritis | 7 | 2020 | 96 | 0.590 |
Why?
|
| Immunoglobulin Fc Fragments | 3 | 2016 | 41 | 0.590 |
Why?
|
| Apoptosis | 25 | 2017 | 2430 | 0.580 |
Why?
|
| Insulin Resistance | 7 | 2019 | 1241 | 0.580 |
Why?
|
| Mitogen-Activated Protein Kinases | 11 | 2004 | 292 | 0.580 |
Why?
|
| Acute-Phase Reaction | 18 | 2008 | 37 | 0.570 |
Why?
|
| Up-Regulation | 18 | 2019 | 852 | 0.570 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 23 | 0.570 |
Why?
|
| Phagosomes | 3 | 2014 | 40 | 0.560 |
Why?
|
| Membranes, Artificial | 10 | 2003 | 75 | 0.560 |
Why?
|
| Fibroblasts | 20 | 2010 | 1034 | 0.560 |
Why?
|
| Islets of Langerhans | 16 | 2014 | 833 | 0.560 |
Why?
|
| Rats | 80 | 2018 | 5614 | 0.560 |
Why?
|
| Ventricular Remodeling | 6 | 2021 | 276 | 0.550 |
Why?
|
| Obesity | 11 | 2018 | 3082 | 0.550 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 2008 | 67 | 0.550 |
Why?
|
| Communicable Diseases | 3 | 2017 | 163 | 0.540 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 83 | 0.540 |
Why?
|
| Gout | 5 | 2021 | 35 | 0.540 |
Why?
|
| Arthritis, Juvenile | 2 | 2011 | 58 | 0.540 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2010 | 237 | 0.540 |
Why?
|
| Endothelium, Vascular | 16 | 2017 | 965 | 0.540 |
Why?
|
| Candidiasis | 7 | 2021 | 64 | 0.540 |
Why?
|
| Ibuprofen | 16 | 2007 | 84 | 0.530 |
Why?
|
| Aging | 12 | 2022 | 1966 | 0.520 |
Why?
|
| Lymphocytes | 16 | 2019 | 382 | 0.520 |
Why?
|
| Acute Disease | 23 | 2018 | 1031 | 0.510 |
Why?
|
| Allergy and Immunology | 3 | 2007 | 42 | 0.510 |
Why?
|
| Interleukin-33 | 5 | 2021 | 45 | 0.510 |
Why?
|
| MAP Kinase Signaling System | 5 | 2014 | 311 | 0.510 |
Why?
|
| Cell Line, Tumor | 23 | 2026 | 3550 | 0.510 |
Why?
|
| Berylliosis | 3 | 2026 | 202 | 0.510 |
Why?
|
| Interferon-alpha | 7 | 2011 | 197 | 0.510 |
Why?
|
| beta-Glucans | 5 | 2024 | 16 | 0.510 |
Why?
|
| Lung | 24 | 2026 | 4109 | 0.500 |
Why?
|
| Parkinson Disease | 1 | 2023 | 600 | 0.490 |
Why?
|
| Base Sequence | 31 | 2017 | 2191 | 0.490 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 120 | 0.480 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2014 | 269 | 0.480 |
Why?
|
| Adenosine Triphosphate | 3 | 2015 | 498 | 0.480 |
Why?
|
| Immunoglobulin G | 12 | 2016 | 893 | 0.480 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 10 | 2009 | 12 | 0.480 |
Why?
|
| Myeloid Cells | 8 | 2017 | 148 | 0.480 |
Why?
|
| Mice, Inbred BALB C | 31 | 2021 | 1253 | 0.480 |
Why?
|
| Cyclooxygenase Inhibitors | 16 | 1996 | 81 | 0.480 |
Why?
|
| Mycobacterium tuberculosis | 6 | 2015 | 337 | 0.470 |
Why?
|
| Behcet Syndrome | 3 | 2013 | 19 | 0.470 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2016 | 364 | 0.470 |
Why?
|
| Mutation | 10 | 2019 | 4099 | 0.470 |
Why?
|
| Molecular Targeted Therapy | 5 | 2020 | 434 | 0.460 |
Why?
|
| Prostaglandins E | 24 | 1990 | 33 | 0.460 |
Why?
|
| Macrophage Activation Syndrome | 5 | 2024 | 22 | 0.460 |
Why?
|
| Aged | 76 | 2025 | 25947 | 0.460 |
Why?
|
| Still's Disease, Adult-Onset | 3 | 2019 | 5 | 0.460 |
Why?
|
| Chlamydophila pneumoniae | 5 | 2004 | 12 | 0.460 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 253 | 0.460 |
Why?
|
| Pneumonia | 4 | 2019 | 631 | 0.460 |
Why?
|
| Caspase Inhibitors | 6 | 2016 | 81 | 0.460 |
Why?
|
| Overweight | 1 | 2020 | 609 | 0.460 |
Why?
|
| Cell Division | 33 | 2009 | 766 | 0.460 |
Why?
|
| Hereditary Autoinflammatory Diseases | 2 | 2015 | 13 | 0.460 |
Why?
|
| Gout Suppressants | 1 | 2015 | 20 | 0.450 |
Why?
|
| Liver | 38 | 2017 | 1888 | 0.450 |
Why?
|
| Myocardial Reperfusion Injury | 5 | 2016 | 137 | 0.450 |
Why?
|
| Repressor Proteins | 4 | 2014 | 437 | 0.450 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2025 | 2147 | 0.450 |
Why?
|
| HLA-DQ Antigens | 1 | 2016 | 173 | 0.450 |
Why?
|
| Aortic Valve | 5 | 2023 | 365 | 0.450 |
Why?
|
| HLA-DR Antigens | 2 | 2016 | 220 | 0.440 |
Why?
|
| Molecular Sequence Data | 33 | 2011 | 2931 | 0.440 |
Why?
|
| Polymorphism, Genetic | 5 | 2020 | 612 | 0.440 |
Why?
|
| Lectins, C-Type | 6 | 2018 | 62 | 0.440 |
Why?
|
| Macrophages, Peritoneal | 12 | 2019 | 89 | 0.430 |
Why?
|
| Lymphokines | 18 | 1996 | 130 | 0.430 |
Why?
|
| Multiple Myeloma | 5 | 2016 | 304 | 0.430 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 11 | 2015 | 338 | 0.430 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 354 | 0.430 |
Why?
|
| alpha-Synuclein | 2 | 2026 | 46 | 0.430 |
Why?
|
| Amino Acid Sequence | 25 | 2020 | 2157 | 0.420 |
Why?
|
| Dextran Sulfate | 8 | 2022 | 94 | 0.420 |
Why?
|
| Liver Diseases | 8 | 2025 | 304 | 0.420 |
Why?
|
| Hepatitis | 5 | 2021 | 43 | 0.420 |
Why?
|
| Growth Substances | 18 | 2002 | 140 | 0.420 |
Why?
|
| Rheumatology | 1 | 2016 | 133 | 0.420 |
Why?
|
| Interferons | 11 | 2024 | 188 | 0.420 |
Why?
|
| Kinetics | 41 | 2012 | 1629 | 0.410 |
Why?
|
| Hidradenitis Suppurativa | 3 | 2020 | 11 | 0.410 |
Why?
|
| Time Factors | 52 | 2017 | 7183 | 0.400 |
Why?
|
| Epigenesis, Genetic | 7 | 2021 | 685 | 0.390 |
Why?
|
| Cell Nucleus | 6 | 2019 | 619 | 0.390 |
Why?
|
| Metabolome | 1 | 2017 | 384 | 0.390 |
Why?
|
| Toll-Like Receptor 2 | 9 | 2016 | 126 | 0.390 |
Why?
|
| Models, Biological | 15 | 2016 | 1822 | 0.390 |
Why?
|
| Neoplasm Metastasis | 3 | 2013 | 695 | 0.390 |
Why?
|
| Disease | 5 | 2011 | 98 | 0.390 |
Why?
|
| Promoter Regions, Genetic | 10 | 2017 | 1258 | 0.390 |
Why?
|
| Hot Temperature | 7 | 2012 | 407 | 0.380 |
Why?
|
| Rare Diseases | 1 | 2014 | 113 | 0.380 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2014 | 96 | 0.380 |
Why?
|
| Chronic Disease | 17 | 2025 | 1813 | 0.380 |
Why?
|
| Superantigens | 7 | 2001 | 70 | 0.380 |
Why?
|
| Complement C3 | 2 | 2013 | 191 | 0.380 |
Why?
|
| Electrocardiography | 3 | 2014 | 663 | 0.370 |
Why?
|
| Drug Synergism | 27 | 2016 | 357 | 0.370 |
Why?
|
| Protein Binding | 16 | 2018 | 2276 | 0.370 |
Why?
|
| Insulin-Secreting Cells | 6 | 2014 | 388 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 1 | 16 | 2019 | 3890 | 0.370 |
Why?
|
| Receptors, CXCR4 | 2 | 2010 | 91 | 0.370 |
Why?
|
| Familial Mediterranean Fever | 4 | 2009 | 7 | 0.370 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2012 | 89 | 0.370 |
Why?
|
| Whole-Body Irradiation | 1 | 2012 | 76 | 0.370 |
Why?
|
| Antigens, CD | 13 | 2015 | 555 | 0.370 |
Why?
|
| HIV Infections | 9 | 2021 | 3154 | 0.360 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2017 | 187 | 0.360 |
Why?
|
| Escherichia coli Infections | 4 | 2000 | 129 | 0.360 |
Why?
|
| Microglia | 4 | 2026 | 269 | 0.360 |
Why?
|
| T-Lymphocytes, Regulatory | 9 | 2021 | 389 | 0.360 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 4 | 2006 | 41 | 0.360 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2021 | 66 | 0.360 |
Why?
|
| Bacterial Infections | 7 | 2004 | 246 | 0.350 |
Why?
|
| Virulence Factors | 5 | 2022 | 174 | 0.350 |
Why?
|
| Cloning, Molecular | 16 | 2008 | 541 | 0.350 |
Why?
|
| Blood Platelets | 5 | 2018 | 400 | 0.350 |
Why?
|
| RNA, Small Interfering | 10 | 2015 | 635 | 0.350 |
Why?
|
| Heart Diseases | 5 | 2014 | 350 | 0.350 |
Why?
|
| Spinal Cord Injuries | 3 | 2021 | 241 | 0.350 |
Why?
|
| Tumor Cells, Cultured | 22 | 2012 | 919 | 0.350 |
Why?
|
| Interferon Type I | 17 | 1998 | 145 | 0.340 |
Why?
|
| Analysis of Variance | 15 | 2011 | 1311 | 0.340 |
Why?
|
| Interleukin-4 | 11 | 1996 | 206 | 0.340 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2016 | 983 | 0.340 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2025 | 676 | 0.340 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2017 | 428 | 0.340 |
Why?
|
| Chemokines | 12 | 2016 | 218 | 0.340 |
Why?
|
| Lipid Metabolism | 4 | 2011 | 528 | 0.340 |
Why?
|
| Virus Replication | 8 | 2011 | 529 | 0.340 |
Why?
|
| Intercellular Adhesion Molecule-1 | 9 | 2017 | 138 | 0.340 |
Why?
|
| Alzheimer Disease | 5 | 2022 | 622 | 0.330 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 14 | 2002 | 161 | 0.330 |
Why?
|
| Immunotherapy | 11 | 2021 | 657 | 0.330 |
Why?
|
| Histamine | 7 | 1994 | 53 | 0.330 |
Why?
|
| Immune Sera | 12 | 2001 | 77 | 0.330 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 7 | 1999 | 168 | 0.330 |
Why?
|
| Myocardium | 13 | 2018 | 939 | 0.330 |
Why?
|
| Acute Coronary Syndrome | 1 | 2014 | 293 | 0.330 |
Why?
|
| Muscle, Skeletal | 3 | 2017 | 1796 | 0.330 |
Why?
|
| Calcinosis | 3 | 2022 | 234 | 0.330 |
Why?
|
| Interferon Inducers | 4 | 1999 | 8 | 0.330 |
Why?
|
| Arteriosclerosis | 6 | 2003 | 84 | 0.320 |
Why?
|
| Fatigue Syndrome, Chronic | 3 | 2017 | 19 | 0.320 |
Why?
|
| CCR5 Receptor Antagonists | 1 | 2010 | 6 | 0.320 |
Why?
|
| Biological Assay | 13 | 2008 | 128 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2019 | 2584 | 0.320 |
Why?
|
| Aspergillosis | 3 | 2016 | 23 | 0.320 |
Why?
|
| Tuberculosis | 5 | 2015 | 291 | 0.320 |
Why?
|
| Immunosuppressive Agents | 9 | 2013 | 847 | 0.310 |
Why?
|
| Aspergillus fumigatus | 5 | 2025 | 25 | 0.310 |
Why?
|
| Transplantation Tolerance | 2 | 2011 | 37 | 0.310 |
Why?
|
| Sodium Chloride | 3 | 2009 | 142 | 0.310 |
Why?
|
| Epithelial Cells | 9 | 2016 | 1126 | 0.310 |
Why?
|
| Concanavalin A | 13 | 2006 | 71 | 0.310 |
Why?
|
| Myocardial Ischemia | 5 | 2009 | 285 | 0.310 |
Why?
|
| Enzyme Activation | 8 | 2015 | 768 | 0.300 |
Why?
|
| beta 2-Microglobulin | 1 | 2009 | 47 | 0.300 |
Why?
|
| Lipopolysaccharide Receptors | 5 | 2015 | 87 | 0.300 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 20 | 0.300 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 7 | 1995 | 16 | 0.300 |
Why?
|
| Reactive Oxygen Species | 8 | 2023 | 621 | 0.300 |
Why?
|
| HEK293 Cells | 4 | 2021 | 744 | 0.300 |
Why?
|
| Myocarditis | 3 | 2016 | 102 | 0.300 |
Why?
|
| Liver Cirrhosis | 4 | 2021 | 288 | 0.300 |
Why?
|
| Cell Differentiation | 15 | 2026 | 2050 | 0.300 |
Why?
|
| Chemokine CCL3 | 2 | 2026 | 26 | 0.300 |
Why?
|
| Double-Blind Method | 19 | 2016 | 2029 | 0.290 |
Why?
|
| Toxemia | 3 | 1994 | 4 | 0.290 |
Why?
|
| Primary Cell Culture | 5 | 2021 | 174 | 0.290 |
Why?
|
| Receptors, Histamine H2 | 3 | 1994 | 6 | 0.290 |
Why?
|
| Sodium, Dietary | 1 | 2009 | 37 | 0.290 |
Why?
|
| Anti-HIV Agents | 5 | 2021 | 888 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 9 | 2017 | 477 | 0.290 |
Why?
|
| Myeloblastin | 4 | 2016 | 8 | 0.290 |
Why?
|
| Transfection | 15 | 2015 | 940 | 0.290 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2456 | 0.290 |
Why?
|
| Stem Cells | 3 | 2023 | 627 | 0.290 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2003 | 452 | 0.290 |
Why?
|
| Aspirin | 3 | 2000 | 400 | 0.290 |
Why?
|
| Blotting, Western | 16 | 2016 | 1187 | 0.280 |
Why?
|
| Cell Adhesion | 16 | 2003 | 455 | 0.280 |
Why?
|
| Synovial Membrane | 5 | 2016 | 124 | 0.280 |
Why?
|
| Macrophages, Alveolar | 6 | 2017 | 368 | 0.280 |
Why?
|
| Treatment Outcome | 22 | 2020 | 11695 | 0.280 |
Why?
|
| Acute-Phase Proteins | 13 | 2002 | 67 | 0.280 |
Why?
|
| Haplotypes | 5 | 2016 | 490 | 0.280 |
Why?
|
| Complement C5a | 10 | 1994 | 54 | 0.280 |
Why?
|
| Choroidal Neovascularization | 1 | 2009 | 57 | 0.280 |
Why?
|
| Prostaglandins | 16 | 1993 | 94 | 0.280 |
Why?
|
| Terminology as Topic | 1 | 2010 | 255 | 0.280 |
Why?
|
| Cell Movement | 11 | 2018 | 965 | 0.280 |
Why?
|
| Protein Structure, Tertiary | 8 | 2015 | 862 | 0.270 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2020 | 97 | 0.270 |
Why?
|
| Injections, Intraperitoneal | 9 | 2015 | 117 | 0.270 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2011 | 239 | 0.270 |
Why?
|
| Alarmins | 2 | 2018 | 27 | 0.270 |
Why?
|
| Receptors, Purinergic P2X7 | 4 | 2015 | 12 | 0.270 |
Why?
|
| Immunologic Surveillance | 2 | 2010 | 25 | 0.270 |
Why?
|
| Leishmania braziliensis | 2 | 2017 | 2 | 0.260 |
Why?
|
| Leishmania mexicana | 2 | 2017 | 2 | 0.260 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 67 | 0.260 |
Why?
|
| Cellulose | 9 | 1996 | 58 | 0.260 |
Why?
|
| Adolescent | 46 | 2018 | 22453 | 0.260 |
Why?
|
| History, 20th Century | 6 | 2011 | 325 | 0.260 |
Why?
|
| Obstetric Labor, Premature | 3 | 1999 | 39 | 0.260 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 78 | 0.260 |
Why?
|
| Tumor Escape | 2 | 2010 | 49 | 0.260 |
Why?
|
| I-kappa B Proteins | 4 | 2005 | 74 | 0.260 |
Why?
|
| Chlamydophila Infections | 2 | 2004 | 5 | 0.260 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2026 | 917 | 0.260 |
Why?
|
| Respiratory Mucosa | 3 | 2016 | 322 | 0.260 |
Why?
|
| Adjuvants, Immunologic | 10 | 2003 | 245 | 0.250 |
Why?
|
| Cognitive Dysfunction | 3 | 2022 | 464 | 0.250 |
Why?
|
| Th17 Cells | 3 | 2012 | 101 | 0.250 |
Why?
|
| Colony-Stimulating Factors | 8 | 2018 | 37 | 0.250 |
Why?
|
| Plastics | 2 | 2025 | 47 | 0.250 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2025 | 2365 | 0.250 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2006 | 3 | 0.250 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1999 | 116 | 0.250 |
Why?
|
| HIV Core Protein p24 | 9 | 2013 | 32 | 0.250 |
Why?
|
| Severity of Illness Index | 14 | 2018 | 2925 | 0.250 |
Why?
|
| Chemokine CXCL1 | 6 | 2021 | 76 | 0.250 |
Why?
|
| Dexamethasone | 7 | 2023 | 372 | 0.250 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2006 | 12 | 0.250 |
Why?
|
| Solubility | 12 | 2007 | 242 | 0.250 |
Why?
|
| Body Temperature Regulation | 9 | 1999 | 108 | 0.250 |
Why?
|
| Serine Proteinase Inhibitors | 4 | 2016 | 51 | 0.240 |
Why?
|
| Hypotension | 4 | 2010 | 126 | 0.240 |
Why?
|
| Keratinocytes | 5 | 2020 | 250 | 0.240 |
Why?
|
| Mice, Mutant Strains | 11 | 2014 | 299 | 0.240 |
Why?
|
| Caspase 3 | 7 | 2014 | 238 | 0.240 |
Why?
|
| Weight Loss | 5 | 2022 | 837 | 0.240 |
Why?
|
| Transplantation Conditioning | 4 | 2017 | 186 | 0.240 |
Why?
|
| Host-Pathogen Interactions | 5 | 2024 | 371 | 0.240 |
Why?
|
| Leukocyte Count | 22 | 2006 | 316 | 0.240 |
Why?
|
| Nitric Oxide | 12 | 2017 | 897 | 0.240 |
Why?
|
| Mitochondria | 3 | 2022 | 984 | 0.240 |
Why?
|
| Brain | 18 | 2021 | 2941 | 0.240 |
Why?
|
| Homeostasis | 4 | 2023 | 640 | 0.230 |
Why?
|
| Neutrophil Activation | 1 | 2006 | 85 | 0.230 |
Why?
|
| Muscles | 9 | 1996 | 333 | 0.230 |
Why?
|
| Zymosan | 4 | 1998 | 39 | 0.230 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2025 | 7 | 0.230 |
Why?
|
| Models, Immunological | 3 | 2021 | 100 | 0.230 |
Why?
|
| Leukemia, Myeloid | 5 | 1999 | 48 | 0.230 |
Why?
|
| Blood Proteins | 7 | 1994 | 249 | 0.230 |
Why?
|
| Intracellular Space | 2 | 2018 | 66 | 0.230 |
Why?
|
| Parkinsonian Disorders | 1 | 2026 | 43 | 0.230 |
Why?
|
| Spleen | 14 | 2017 | 508 | 0.230 |
Why?
|
| Phytohemagglutinins | 14 | 1996 | 29 | 0.230 |
Why?
|
| Gastrointestinal Diseases | 2 | 2025 | 216 | 0.230 |
Why?
|
| Nitric Oxide Synthase | 5 | 2002 | 235 | 0.230 |
Why?
|
| Adalimumab | 3 | 2020 | 55 | 0.230 |
Why?
|
| Chemotaxis, Leukocyte | 7 | 2011 | 113 | 0.230 |
Why?
|
| Neutralization Tests | 7 | 2015 | 76 | 0.220 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 2 | 2019 | 12 | 0.220 |
Why?
|
| Young Adult | 18 | 2020 | 14126 | 0.220 |
Why?
|
| Angiopoietins | 2 | 2015 | 13 | 0.220 |
Why?
|
| Liver Neoplasms | 8 | 2011 | 783 | 0.220 |
Why?
|
| Cell Death | 6 | 2025 | 383 | 0.220 |
Why?
|
| Cytotoxicity, Immunologic | 12 | 2014 | 223 | 0.220 |
Why?
|
| Ventricular Function, Left | 5 | 2017 | 541 | 0.220 |
Why?
|
| Alleles | 6 | 2017 | 881 | 0.220 |
Why?
|
| Mice, Inbred C3H | 20 | 2008 | 251 | 0.220 |
Why?
|
| Immune System | 4 | 2016 | 179 | 0.220 |
Why?
|
| Flow Cytometry | 10 | 2015 | 1173 | 0.220 |
Why?
|
| Acute Kidney Injury | 7 | 2017 | 866 | 0.220 |
Why?
|
| Tetradecanoylphorbol Acetate | 14 | 1996 | 153 | 0.220 |
Why?
|
| Agranulocytosis | 3 | 1989 | 30 | 0.210 |
Why?
|
| Skin | 10 | 2019 | 758 | 0.210 |
Why?
|
| Myocardial Contraction | 6 | 2012 | 298 | 0.210 |
Why?
|
| Cryopyrin-Associated Periodic Syndromes | 2 | 2015 | 6 | 0.210 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 735 | 0.210 |
Why?
|
| Tacrolimus | 2 | 2017 | 196 | 0.210 |
Why?
|
| Pseudomonas Infections | 6 | 2016 | 221 | 0.210 |
Why?
|
| Real-Time Polymerase Chain Reaction | 6 | 2014 | 341 | 0.210 |
Why?
|
| Phosphorylation | 8 | 2018 | 1733 | 0.210 |
Why?
|
| Leptin | 7 | 2008 | 245 | 0.210 |
Why?
|
| Down-Regulation | 8 | 2020 | 627 | 0.210 |
Why?
|
| Ultrafiltration | 5 | 1996 | 30 | 0.210 |
Why?
|
| Diet, High-Fat | 4 | 2018 | 261 | 0.210 |
Why?
|
| Macrophage Inflammatory Proteins | 3 | 2005 | 11 | 0.200 |
Why?
|
| Cell Wall | 5 | 2016 | 61 | 0.200 |
Why?
|
| Multigene Family | 6 | 2019 | 204 | 0.200 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 5 | 2004 | 74 | 0.200 |
Why?
|
| Intestines | 2 | 2017 | 358 | 0.200 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2017 | 266 | 0.200 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2016 | 72 | 0.200 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2024 | 76 | 0.200 |
Why?
|
| Transplantation, Homologous | 8 | 2016 | 415 | 0.200 |
Why?
|
| Immobilized Proteins | 2 | 2015 | 10 | 0.200 |
Why?
|
| Exercise Test | 3 | 2017 | 634 | 0.200 |
Why?
|
| Bone Marrow Transplantation | 5 | 2011 | 294 | 0.200 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 7 | 2006 | 81 | 0.200 |
Why?
|
| Spinal Cord | 3 | 2021 | 382 | 0.200 |
Why?
|
| Disease Progression | 11 | 2026 | 2852 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 7 | 2021 | 479 | 0.200 |
Why?
|
| Pilot Projects | 10 | 2016 | 1890 | 0.200 |
Why?
|
| Tumor Burden | 3 | 2021 | 322 | 0.200 |
Why?
|
| Cell Communication | 5 | 2021 | 324 | 0.200 |
Why?
|
| Enterotoxins | 7 | 2001 | 89 | 0.200 |
Why?
|
| Glycolysis | 3 | 2021 | 340 | 0.200 |
Why?
|
| Hypersensitivity | 4 | 2018 | 252 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2018 | 392 | 0.200 |
Why?
|
| Hypothalamus | 8 | 1997 | 153 | 0.200 |
Why?
|
| Endothelium | 11 | 1989 | 119 | 0.200 |
Why?
|
| Fibrosarcoma | 4 | 2007 | 23 | 0.200 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2003 | 26 | 0.200 |
Why?
|
| CHO Cells | 5 | 2013 | 171 | 0.200 |
Why?
|
| Glycation End Products, Advanced | 1 | 2004 | 82 | 0.200 |
Why?
|
| Nod2 Signaling Adaptor Protein | 5 | 2013 | 34 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 8 | 2016 | 356 | 0.190 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2015 | 339 | 0.190 |
Why?
|
| Glucose | 10 | 2019 | 1049 | 0.190 |
Why?
|
| RNA Stability | 1 | 2004 | 119 | 0.190 |
Why?
|
| Survival Analysis | 11 | 2020 | 1385 | 0.190 |
Why?
|
| Neoplasms, Experimental | 4 | 2010 | 173 | 0.190 |
Why?
|
| Pulmonary Alveoli | 5 | 2012 | 383 | 0.190 |
Why?
|
| Cricetinae | 5 | 2013 | 304 | 0.190 |
Why?
|
| Macrophage Activation | 10 | 2015 | 193 | 0.190 |
Why?
|
| Hemodiafiltration | 1 | 2003 | 7 | 0.190 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2013 | 40 | 0.190 |
Why?
|
| Reference Values | 10 | 2022 | 798 | 0.190 |
Why?
|
| Cyclooxygenase 2 | 5 | 2005 | 165 | 0.190 |
Why?
|
| Binding Sites | 9 | 2003 | 1331 | 0.190 |
Why?
|
| Serpins | 1 | 2022 | 28 | 0.190 |
Why?
|
| Dopaminergic Neurons | 1 | 2023 | 67 | 0.190 |
Why?
|
| Serine Endopeptidases | 3 | 2016 | 128 | 0.190 |
Why?
|
| Serum Amyloid A Protein | 10 | 2011 | 32 | 0.190 |
Why?
|
| Borrelia burgdorferi Group | 2 | 1992 | 7 | 0.190 |
Why?
|
| Crohn Disease | 5 | 2006 | 260 | 0.190 |
Why?
|
| Stress, Physiological | 2 | 2017 | 453 | 0.190 |
Why?
|
| Drug Resistance | 5 | 2013 | 153 | 0.180 |
Why?
|
| Muscle Proteins | 4 | 1996 | 244 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 4 | 1996 | 592 | 0.180 |
Why?
|
| Indomethacin | 18 | 1996 | 76 | 0.180 |
Why?
|
| Drug Design | 3 | 2012 | 173 | 0.180 |
Why?
|
| Corticosterone | 9 | 2005 | 244 | 0.180 |
Why?
|
| Platelet Activation | 4 | 2018 | 104 | 0.180 |
Why?
|
| DNA | 14 | 2008 | 1464 | 0.180 |
Why?
|
| Ovalbumin | 3 | 2019 | 190 | 0.180 |
Why?
|
| Kidney Tubular Necrosis, Acute | 2 | 2017 | 26 | 0.180 |
Why?
|
| Anorexia | 3 | 1995 | 17 | 0.180 |
Why?
|
| Molecular Weight | 15 | 2006 | 327 | 0.180 |
Why?
|
| Body Weight | 7 | 2018 | 978 | 0.180 |
Why?
|
| Phagocytosis | 14 | 2015 | 299 | 0.180 |
Why?
|
| Follow-Up Studies | 12 | 2017 | 5417 | 0.180 |
Why?
|
| Erdheim-Chester Disease | 1 | 2021 | 4 | 0.180 |
Why?
|
| Reperfusion Injury | 3 | 2017 | 300 | 0.180 |
Why?
|
| Leukocyte Elastase | 4 | 2016 | 75 | 0.180 |
Why?
|
| Proteostasis | 1 | 2022 | 27 | 0.180 |
Why?
|
| Lymph Nodes | 7 | 2017 | 502 | 0.180 |
Why?
|
| Organoids | 1 | 2023 | 141 | 0.180 |
Why?
|
| Isoenzymes | 4 | 2004 | 299 | 0.180 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 212 | 0.180 |
Why?
|
| Immunity | 6 | 2021 | 139 | 0.170 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2017 | 47 | 0.170 |
Why?
|
| DNA-Binding Proteins | 10 | 2005 | 1500 | 0.170 |
Why?
|
| Peptide Fragments | 5 | 2015 | 699 | 0.170 |
Why?
|
| Glucose Tolerance Test | 4 | 2018 | 361 | 0.170 |
Why?
|
| Cholesterol, HDL | 3 | 2018 | 200 | 0.170 |
Why?
|
| Neutrophil Infiltration | 5 | 2020 | 104 | 0.170 |
Why?
|
| Limulus Test | 7 | 1989 | 7 | 0.170 |
Why?
|
| Case-Control Studies | 11 | 2021 | 3608 | 0.170 |
Why?
|
| Umbilical Veins | 8 | 2009 | 59 | 0.170 |
Why?
|
| Dietary Fats | 3 | 2014 | 315 | 0.170 |
Why?
|
| Structure-Activity Relationship | 10 | 2003 | 570 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2014 | 420 | 0.170 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 3 | 2014 | 55 | 0.170 |
Why?
|
| Cell Proliferation | 7 | 2021 | 2499 | 0.170 |
Why?
|
| Acute Lung Injury | 3 | 2016 | 303 | 0.170 |
Why?
|
| Oxidative Stress | 4 | 2024 | 1339 | 0.170 |
Why?
|
| Transcriptome | 2 | 2026 | 1046 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 12 | 2011 | 1054 | 0.170 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2024 | 194 | 0.170 |
Why?
|
| Kupffer Cells | 1 | 2021 | 53 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type II | 6 | 2010 | 162 | 0.170 |
Why?
|
| RNA-Binding Proteins | 4 | 2021 | 464 | 0.160 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2018 | 116 | 0.160 |
Why?
|
| Hemodynamics | 9 | 2018 | 1121 | 0.160 |
Why?
|
| Eating | 5 | 2018 | 392 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 1721 | 0.160 |
Why?
|
| Culture Media | 12 | 2011 | 161 | 0.160 |
Why?
|
| Fatty Acids | 7 | 1998 | 452 | 0.160 |
Why?
|
| Nanoparticles | 2 | 2025 | 520 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2022 | 389 | 0.160 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 28 | 0.160 |
Why?
|
| Pulmonary Emphysema | 2 | 2013 | 275 | 0.160 |
Why?
|
| COS Cells | 6 | 2004 | 181 | 0.160 |
Why?
|
| Aged, 80 and over | 21 | 2020 | 8279 | 0.160 |
Why?
|
| Antigens | 3 | 2013 | 347 | 0.160 |
Why?
|
| Shock | 3 | 1991 | 108 | 0.160 |
Why?
|
| Brain Injuries | 3 | 2015 | 508 | 0.160 |
Why?
|
| Staphylococcus aureus | 5 | 2003 | 460 | 0.160 |
Why?
|
| Genotype | 5 | 2020 | 1835 | 0.160 |
Why?
|
| Interleukin-23 | 2 | 2011 | 16 | 0.160 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 80 | 0.160 |
Why?
|
| Parvovirus | 3 | 2017 | 13 | 0.160 |
Why?
|
| Leishmaniasis, Visceral | 2 | 2018 | 24 | 0.160 |
Why?
|
| Thyroid Neoplasms | 2 | 2015 | 346 | 0.160 |
Why?
|
| Immunity, Mucosal | 1 | 2021 | 98 | 0.160 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2018 | 37 | 0.160 |
Why?
|
| Kidney | 11 | 2017 | 1496 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 2 | 2012 | 156 | 0.160 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 | 1994 | 127 | 0.160 |
Why?
|
| Eligibility Determination | 1 | 2020 | 68 | 0.160 |
Why?
|
| Protein Transport | 3 | 2019 | 441 | 0.160 |
Why?
|
| NADPH Oxidases | 4 | 2014 | 124 | 0.160 |
Why?
|
| Immunologic Memory | 2 | 2021 | 366 | 0.160 |
Why?
|
| Polymers | 5 | 2007 | 499 | 0.160 |
Why?
|
| Human Genome Project | 2 | 2016 | 15 | 0.160 |
Why?
|
| Antigens, CD19 | 1 | 2020 | 129 | 0.150 |
Why?
|
| Salmonella Infections, Animal | 1 | 2000 | 39 | 0.150 |
Why?
|
| Hepatocytes | 3 | 2018 | 224 | 0.150 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 1993 | 142 | 0.150 |
Why?
|
| Peptide Initiation Factors | 2 | 2010 | 16 | 0.150 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 82 | 0.150 |
Why?
|
| Blood Pressure | 8 | 2018 | 1769 | 0.150 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 292 | 0.150 |
Why?
|
| Asthma | 2 | 2021 | 1768 | 0.150 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2021 | 451 | 0.150 |
Why?
|
| Methotrexate | 3 | 2017 | 240 | 0.150 |
Why?
|
| Pregnancy, Animal | 1 | 2000 | 52 | 0.150 |
Why?
|
| Phosphoproteins | 6 | 2009 | 346 | 0.150 |
Why?
|
| Antiviral Agents | 4 | 2016 | 768 | 0.150 |
Why?
|
| Chemokine CCL4 | 3 | 2026 | 31 | 0.150 |
Why?
|
| Myelin Sheath | 1 | 2021 | 168 | 0.150 |
Why?
|
| Lyme Disease | 2 | 2018 | 58 | 0.150 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 226 | 0.150 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 444 | 0.150 |
Why?
|
| A549 Cells | 1 | 2019 | 75 | 0.150 |
Why?
|
| Osteogenesis | 2 | 2022 | 208 | 0.150 |
Why?
|
| Energy Metabolism | 7 | 2018 | 936 | 0.150 |
Why?
|
| Coronary Vessels | 1 | 2021 | 251 | 0.150 |
Why?
|
| Skin Neoplasms | 3 | 2017 | 847 | 0.150 |
Why?
|
| Membrane Proteins | 8 | 2021 | 1167 | 0.150 |
Why?
|
| Pyrazoles | 3 | 2021 | 510 | 0.150 |
Why?
|
| Thrombin | 5 | 2009 | 166 | 0.150 |
Why?
|
| Collagen | 7 | 2011 | 456 | 0.150 |
Why?
|
| Peptides | 5 | 2026 | 998 | 0.150 |
Why?
|
| Uterine Diseases | 1 | 1999 | 18 | 0.150 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1999 | 7 | 0.150 |
Why?
|
| Myocytes, Cardiac | 3 | 2018 | 556 | 0.150 |
Why?
|
| Salmonella typhimurium | 2 | 2002 | 190 | 0.150 |
Why?
|
| Risk | 2 | 2020 | 911 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 3 | 2016 | 220 | 0.150 |
Why?
|
| Depsipeptides | 1 | 2019 | 15 | 0.150 |
Why?
|
| Palmitic Acid | 2 | 2019 | 42 | 0.150 |
Why?
|
| Phospholipases A | 2 | 2002 | 98 | 0.150 |
Why?
|
| Cohort Studies | 8 | 2020 | 5965 | 0.150 |
Why?
|
| Macrophage-1 Antigen | 3 | 2014 | 26 | 0.150 |
Why?
|
| Neutropenia | 3 | 1999 | 155 | 0.140 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2005 | 20 | 0.140 |
Why?
|
| Chlamydia Infections | 1 | 2000 | 81 | 0.140 |
Why?
|
| Stem Cell Factor | 2 | 1998 | 17 | 0.140 |
Why?
|
| Oxidation-Reduction | 6 | 2022 | 1087 | 0.140 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2013 | 147 | 0.140 |
Why?
|
| Diabetes Mellitus | 3 | 2013 | 1098 | 0.140 |
Why?
|
| Rats, Inbred Strains | 22 | 1998 | 321 | 0.140 |
Why?
|
| Arthritis, Reactive | 1 | 2018 | 7 | 0.140 |
Why?
|
| Binding, Competitive | 13 | 2001 | 193 | 0.140 |
Why?
|
| Biocompatible Materials | 4 | 1996 | 435 | 0.140 |
Why?
|
| Hospitals, University | 3 | 2016 | 176 | 0.140 |
Why?
|
| Acrylic Resins | 2 | 1989 | 45 | 0.140 |
Why?
|
| Mice, Inbred DBA | 4 | 2006 | 187 | 0.140 |
Why?
|
| Leishmania infantum | 1 | 2018 | 8 | 0.140 |
Why?
|
| Plasma | 3 | 2015 | 225 | 0.140 |
Why?
|
| Streptococcus pneumoniae | 3 | 2017 | 177 | 0.140 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2018 | 13 | 0.140 |
Why?
|
| Exanthema | 1 | 2019 | 84 | 0.140 |
Why?
|
| Leukemia, Hairy Cell | 1 | 1998 | 7 | 0.140 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2017 | 191 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 14 | 2018 | 2540 | 0.140 |
Why?
|
| Protein Structure, Secondary | 2 | 2011 | 369 | 0.140 |
Why?
|
| Th2 Cells | 3 | 2021 | 171 | 0.140 |
Why?
|
| Borrelia burgdorferi | 1 | 2018 | 21 | 0.140 |
Why?
|
| Mice, Inbred Strains | 12 | 2008 | 397 | 0.140 |
Why?
|
| omega-N-Methylarginine | 1 | 1997 | 29 | 0.140 |
Why?
|
| Chemokine CCL2 | 6 | 2017 | 116 | 0.140 |
Why?
|
| Lysine | 2 | 2010 | 302 | 0.130 |
Why?
|
| Receptors, Interleukin-1 Type II | 5 | 2008 | 5 | 0.130 |
Why?
|
| Protective Factors | 1 | 2018 | 99 | 0.130 |
Why?
|
| Lipids | 7 | 2018 | 710 | 0.130 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 1991 | 34 | 0.130 |
Why?
|
| DNA, Complementary | 4 | 2007 | 277 | 0.130 |
Why?
|
| Klebsiella Infections | 4 | 1995 | 26 | 0.130 |
Why?
|
| DNA Primers | 8 | 2011 | 512 | 0.130 |
Why?
|
| Chromatin | 2 | 2014 | 561 | 0.130 |
Why?
|
| Protein Multimerization | 1 | 2019 | 214 | 0.130 |
Why?
|
| Glutathione | 2 | 2018 | 375 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2021 | 533 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 437 | 0.130 |
Why?
|
| Unrelated Donors | 1 | 2017 | 38 | 0.130 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2017 | 14 | 0.130 |
Why?
|
| Genetic Variation | 2 | 2021 | 984 | 0.130 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 493 | 0.130 |
Why?
|
| Bone Marrow | 4 | 2015 | 306 | 0.130 |
Why?
|
| Lipoproteins | 2 | 2017 | 169 | 0.130 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 15 | 0.130 |
Why?
|
| Prospective Studies | 14 | 2018 | 7997 | 0.130 |
Why?
|
| Polymyxin B | 9 | 1996 | 20 | 0.130 |
Why?
|
| Administration, Oral | 5 | 2020 | 848 | 0.130 |
Why?
|
| Immunohistochemistry | 12 | 2016 | 1718 | 0.130 |
Why?
|
| Feeding and Eating Disorders | 2 | 1990 | 163 | 0.130 |
Why?
|
| Drug Delivery Systems | 2 | 2012 | 381 | 0.130 |
Why?
|
| Adenosine | 2 | 2015 | 255 | 0.130 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 1993 | 24 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2021 | 557 | 0.130 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1996 | 50 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 1995 | 683 | 0.130 |
Why?
|
| Fumarates | 1 | 2016 | 10 | 0.130 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1997 | 42 | 0.130 |
Why?
|
| Schistosomiasis mansoni | 3 | 2011 | 25 | 0.130 |
Why?
|
| CARD Signaling Adaptor Proteins | 3 | 2016 | 22 | 0.130 |
Why?
|
| Chemotactic Factors | 4 | 2002 | 43 | 0.130 |
Why?
|
| Heart | 5 | 2009 | 636 | 0.130 |
Why?
|
| Extracellular Space | 3 | 2015 | 120 | 0.120 |
Why?
|
| Cell Respiration | 1 | 2017 | 107 | 0.120 |
Why?
|
| Immunoglobulins | 4 | 2016 | 160 | 0.120 |
Why?
|
| Bacteria | 2 | 2022 | 889 | 0.120 |
Why?
|
| Calcium | 9 | 2022 | 1184 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 326 | 0.120 |
Why?
|
| Indoles | 3 | 2015 | 501 | 0.120 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 264 | 0.120 |
Why?
|
| Fibrosis | 6 | 2021 | 548 | 0.120 |
Why?
|
| Klebsiella pneumoniae | 2 | 1995 | 47 | 0.120 |
Why?
|
| Peptidoglycan | 3 | 2007 | 28 | 0.120 |
Why?
|
| Cerebral Ventricles | 4 | 1993 | 54 | 0.120 |
Why?
|
| Streptococcus | 1 | 2016 | 29 | 0.120 |
Why?
|
| Myoblasts | 1 | 2017 | 84 | 0.120 |
Why?
|
| Mice, Inbred ICR | 3 | 2012 | 113 | 0.120 |
Why?
|
| Drosophila | 1 | 2018 | 166 | 0.120 |
Why?
|
| Wound Healing | 2 | 2017 | 351 | 0.120 |
Why?
|
| Synovitis | 1 | 2016 | 33 | 0.120 |
Why?
|
| Injections, Intravenous | 7 | 2020 | 200 | 0.120 |
Why?
|
| Mannose-Binding Lectins | 1 | 1996 | 10 | 0.120 |
Why?
|
| Sugar Phosphates | 1 | 2016 | 3 | 0.120 |
Why?
|
| Glutamine | 1 | 2016 | 109 | 0.120 |
Why?
|
| Kidneys, Artificial | 4 | 1993 | 6 | 0.120 |
Why?
|
| CD28 Antigens | 2 | 2013 | 58 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 631 | 0.120 |
Why?
|
| Transcription Factor AP-1 | 2 | 2008 | 79 | 0.120 |
Why?
|
| Caspases | 5 | 2022 | 232 | 0.120 |
Why?
|
| Potassium Iodide | 1 | 1995 | 4 | 0.120 |
Why?
|
| Disaccharides | 1 | 2016 | 21 | 0.120 |
Why?
|
| Pancreas | 3 | 2012 | 342 | 0.120 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2003 | 328 | 0.120 |
Why?
|
| Streptococcus pyogenes | 2 | 2010 | 41 | 0.120 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 2 | 2007 | 29 | 0.120 |
Why?
|
| Helminth Proteins | 2 | 2011 | 24 | 0.120 |
Why?
|
| HLA-A Antigens | 1 | 2016 | 52 | 0.120 |
Why?
|
| Carbamates | 2 | 2015 | 52 | 0.120 |
Why?
|
| Oseltamivir | 1 | 2016 | 15 | 0.120 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2016 | 32 | 0.120 |
Why?
|
| Immunization, Passive | 3 | 1991 | 87 | 0.120 |
Why?
|
| Body Constitution | 1 | 1996 | 51 | 0.120 |
Why?
|
| Cytosol | 4 | 2009 | 227 | 0.120 |
Why?
|
| Cardiovascular System | 1 | 2017 | 138 | 0.120 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 1989 | 65 | 0.120 |
Why?
|
| Histones | 5 | 2017 | 670 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 210 | 0.120 |
Why?
|
| Complement Activation | 5 | 1996 | 411 | 0.120 |
Why?
|
| Acetylation | 5 | 2017 | 256 | 0.110 |
Why?
|
| Gene Expression Profiling | 6 | 2021 | 1786 | 0.110 |
Why?
|
| Hepatitis C, Chronic | 2 | 2011 | 152 | 0.110 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2015 | 41 | 0.110 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 76 | 0.110 |
Why?
|
| Cachexia | 5 | 1998 | 75 | 0.110 |
Why?
|
| Linoleic Acid | 1 | 2015 | 44 | 0.110 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2015 | 69 | 0.110 |
Why?
|
| Oleic Acid | 1 | 2015 | 42 | 0.110 |
Why?
|
| Dose-Response Relationship, Immunologic | 8 | 2006 | 76 | 0.110 |
Why?
|
| Injections, Intra-Articular | 1 | 2015 | 58 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 1996 | 144 | 0.110 |
Why?
|
| Species Specificity | 10 | 2001 | 574 | 0.110 |
Why?
|
| Hepatitis, Chronic | 1 | 1995 | 5 | 0.110 |
Why?
|
| Gene-Environment Interaction | 1 | 2016 | 180 | 0.110 |
Why?
|
| CD11b Antigen | 3 | 2018 | 60 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 359 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
|
| Viral Load | 2 | 2015 | 526 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2020 | 396 | 0.110 |
Why?
|
| Fasciitis, Necrotizing | 2 | 2006 | 15 | 0.110 |
Why?
|
| Infusions, Intravenous | 7 | 2020 | 423 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
|
| Glucocorticoids | 5 | 2005 | 535 | 0.110 |
Why?
|
| Triglycerides | 5 | 2011 | 521 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 927 | 0.110 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1995 | 25 | 0.110 |
Why?
|
| Caspase 7 | 1 | 2014 | 22 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 1462 | 0.110 |
Why?
|
| Ureteral Obstruction | 2 | 2006 | 62 | 0.110 |
Why?
|
| Disease Susceptibility | 5 | 2021 | 348 | 0.110 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2014 | 4 | 0.110 |
Why?
|
| Labor, Obstetric | 2 | 1992 | 66 | 0.110 |
Why?
|
| Hepatitis C | 2 | 1995 | 254 | 0.110 |
Why?
|
| Interleukin-16 | 2 | 2017 | 6 | 0.110 |
Why?
|
| Cellulitis | 2 | 2006 | 53 | 0.110 |
Why?
|
| Thymus Gland | 6 | 2005 | 311 | 0.110 |
Why?
|
| Running | 2 | 2017 | 228 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 91 | 0.110 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1994 | 18 | 0.110 |
Why?
|
| Graft Survival | 2 | 2011 | 526 | 0.110 |
Why?
|
| Blood | 5 | 2016 | 109 | 0.110 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2014 | 12 | 0.110 |
Why?
|
| Protease Inhibitors | 1 | 1995 | 102 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 164 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 2015 | 249 | 0.110 |
Why?
|
| Glomerulonephritis | 1 | 1995 | 45 | 0.110 |
Why?
|
| Candida | 1 | 2014 | 44 | 0.110 |
Why?
|
| Cross-Over Studies | 3 | 2015 | 601 | 0.110 |
Why?
|
| Meningococcal Infections | 2 | 1997 | 26 | 0.110 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 243 | 0.110 |
Why?
|
| Silicosis | 1 | 2015 | 30 | 0.110 |
Why?
|
| Ligands | 5 | 2015 | 674 | 0.110 |
Why?
|
| Gene Silencing | 3 | 2011 | 205 | 0.110 |
Why?
|
| Blotting, Northern | 9 | 1994 | 204 | 0.110 |
Why?
|
| Ozone | 2 | 2007 | 132 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 192 | 0.110 |
Why?
|
| Turpentine | 4 | 1998 | 5 | 0.110 |
Why?
|
| Protein Conformation | 8 | 2009 | 946 | 0.110 |
Why?
|
| Fatigue | 1 | 2017 | 366 | 0.110 |
Why?
|
| Fungal Polysaccharides | 1 | 2014 | 2 | 0.110 |
Why?
|
| Schistosoma mansoni | 3 | 2011 | 41 | 0.100 |
Why?
|
| Burns | 4 | 1995 | 377 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 336 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 167 | 0.100 |
Why?
|
| Obstetric Labor Complications | 2 | 1992 | 38 | 0.100 |
Why?
|
| Synovial Fluid | 6 | 2009 | 67 | 0.100 |
Why?
|
| Butyrates | 1 | 2015 | 67 | 0.100 |
Why?
|
| Cats | 8 | 1993 | 228 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 2 | 2019 | 151 | 0.100 |
Why?
|
| Stroke Volume | 2 | 2016 | 651 | 0.100 |
Why?
|
| Dengue | 1 | 2015 | 89 | 0.100 |
Why?
|
| Cisplatin | 2 | 2007 | 334 | 0.100 |
Why?
|
| Necrosis | 6 | 2010 | 244 | 0.100 |
Why?
|
| Parvoviridae Infections | 1 | 2013 | 12 | 0.100 |
Why?
|
| Cardiomegaly | 2 | 2013 | 174 | 0.100 |
Why?
|
| Child | 21 | 2016 | 22657 | 0.100 |
Why?
|
| Food, Fortified | 1 | 1993 | 44 | 0.100 |
Why?
|
| Glucans | 1 | 1993 | 22 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2014 | 121 | 0.100 |
Why?
|
| Microbiota | 3 | 2017 | 781 | 0.100 |
Why?
|
| Superoxides | 6 | 2014 | 204 | 0.100 |
Why?
|
| Oncogenes | 2 | 2021 | 119 | 0.100 |
Why?
|
| Autophagy-Related Proteins | 1 | 2013 | 46 | 0.100 |
Why?
|
| Ischemia | 2 | 2011 | 421 | 0.100 |
Why?
|
| Polysaccharides | 1 | 2014 | 87 | 0.100 |
Why?
|
| Ethanol | 2 | 2017 | 627 | 0.100 |
Why?
|
| Hypertriglyceridemia | 2 | 2010 | 44 | 0.100 |
Why?
|
| Body Composition | 5 | 2018 | 706 | 0.100 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1994 | 126 | 0.100 |
Why?
|
| Kidney Diseases | 2 | 2008 | 427 | 0.100 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2004 | 96 | 0.100 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2013 | 5 | 0.100 |
Why?
|
| Rheumatic Fever | 1 | 2013 | 5 | 0.100 |
Why?
|
| Protein Kinase C | 3 | 1992 | 252 | 0.100 |
Why?
|
| Receptors, Interleukin-2 | 6 | 2010 | 64 | 0.100 |
Why?
|
| Colon | 6 | 2019 | 305 | 0.100 |
Why?
|
| Microbial Collagenase | 3 | 1990 | 8 | 0.100 |
Why?
|
| Ileitis | 1 | 2013 | 33 | 0.100 |
Why?
|
| Platelet Activating Factor | 4 | 2002 | 49 | 0.100 |
Why?
|
| Mycophenolic Acid | 1 | 2013 | 120 | 0.100 |
Why?
|
| Cricetulus | 2 | 2013 | 118 | 0.100 |
Why?
|
| Blood Coagulation | 5 | 2018 | 268 | 0.100 |
Why?
|
| Vaccines, DNA | 2 | 2003 | 31 | 0.100 |
Why?
|
| Eicosanoids | 1 | 1993 | 58 | 0.090 |
Why?
|
| Imidazoles | 6 | 2004 | 254 | 0.090 |
Why?
|
| Cell Count | 7 | 2008 | 321 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 5 | 2013 | 636 | 0.090 |
Why?
|
| Peritoneal Dialysis | 2 | 1985 | 100 | 0.090 |
Why?
|
| Drug Administration Schedule | 3 | 2010 | 783 | 0.090 |
Why?
|
| Adipocytes | 1 | 2014 | 223 | 0.090 |
Why?
|
| Fetal Blood | 3 | 1990 | 342 | 0.090 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 2 | 2013 | 59 | 0.090 |
Why?
|
| Antigens, Helminth | 2 | 2011 | 16 | 0.090 |
Why?
|
| Biological Products | 6 | 1988 | 252 | 0.090 |
Why?
|
| Monokines | 9 | 2004 | 21 | 0.090 |
Why?
|
| Thromboxane B2 | 3 | 1989 | 23 | 0.090 |
Why?
|
| Valproic Acid | 2 | 2010 | 48 | 0.090 |
Why?
|
| Colchicine | 4 | 1995 | 21 | 0.090 |
Why?
|
| Exons | 5 | 2004 | 358 | 0.090 |
Why?
|
| Oligopeptides | 4 | 2011 | 269 | 0.090 |
Why?
|
| Mycobacterium Infections | 1 | 2013 | 61 | 0.090 |
Why?
|
| DNA Damage | 1 | 2015 | 430 | 0.090 |
Why?
|
| Histone Deacetylase 1 | 1 | 2012 | 23 | 0.090 |
Why?
|
| Transgenes | 3 | 2019 | 190 | 0.090 |
Why?
|
| Sequence Deletion | 3 | 2004 | 193 | 0.090 |
Why?
|
| Blood Vessels | 3 | 1992 | 171 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2003 | 319 | 0.090 |
Why?
|
| Survival Rate | 6 | 2018 | 2092 | 0.090 |
Why?
|
| Virus Latency | 1 | 2013 | 90 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2014 | 381 | 0.090 |
Why?
|
| Granulocytes | 3 | 2005 | 80 | 0.090 |
Why?
|
| Cystic Fibrosis | 2 | 2016 | 1158 | 0.090 |
Why?
|
| Streptococcal Infections | 2 | 2000 | 169 | 0.090 |
Why?
|
| Methylcholanthrene | 2 | 2009 | 21 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2021 | 159 | 0.090 |
Why?
|
| Cell Separation | 11 | 1997 | 307 | 0.090 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1992 | 34 | 0.090 |
Why?
|
| Thiadiazines | 1 | 1991 | 1 | 0.090 |
Why?
|
| Antigens, Fungal | 1 | 2012 | 28 | 0.090 |
Why?
|
| Adrenocorticotropic Hormone | 5 | 1994 | 147 | 0.090 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 27 | 0.090 |
Why?
|
| Physical Exertion | 3 | 1989 | 207 | 0.090 |
Why?
|
| Chemokines, CXC | 2 | 2002 | 68 | 0.090 |
Why?
|
| Sequence Alignment | 2 | 2005 | 368 | 0.090 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2011 | 32 | 0.090 |
Why?
|
| Cartilage | 3 | 1990 | 198 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 732 | 0.090 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 1389 | 0.090 |
Why?
|
| Clinical Trials, Phase II as Topic | 2 | 2020 | 77 | 0.090 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2011 | 26 | 0.090 |
Why?
|
| Antigens, Bacterial | 3 | 2010 | 127 | 0.090 |
Why?
|
| Genetic Engineering | 2 | 2010 | 93 | 0.090 |
Why?
|
| Adiponectin | 3 | 2014 | 244 | 0.090 |
Why?
|
| Focal Adhesions | 1 | 2011 | 47 | 0.090 |
Why?
|
| Cell Membrane | 4 | 2007 | 706 | 0.090 |
Why?
|
| Pneumonia, Bacterial | 2 | 2003 | 113 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 5 | 1996 | 235 | 0.090 |
Why?
|
| Drug Contamination | 3 | 1998 | 52 | 0.090 |
Why?
|
| Taurine | 1 | 1991 | 41 | 0.090 |
Why?
|
| Placebos | 5 | 2020 | 193 | 0.090 |
Why?
|
| Isoproterenol | 1 | 2011 | 97 | 0.090 |
Why?
|
| Peroxidase | 6 | 2005 | 168 | 0.090 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2011 | 13 | 0.090 |
Why?
|
| Phenols | 2 | 1995 | 114 | 0.080 |
Why?
|
| Cell Migration Inhibition | 2 | 2009 | 16 | 0.080 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 80 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2014 | 424 | 0.080 |
Why?
|
| Immunization | 3 | 2018 | 374 | 0.080 |
Why?
|
| Antioxidants | 1 | 2015 | 549 | 0.080 |
Why?
|
| Colitis, Ulcerative | 3 | 2005 | 148 | 0.080 |
Why?
|
| Herpesvirus 2, Human | 1 | 2011 | 27 | 0.080 |
Why?
|
| G1 Phase | 1 | 1991 | 66 | 0.080 |
Why?
|
| Drug Tolerance | 5 | 2020 | 100 | 0.080 |
Why?
|
| Triggering Receptor Expressed on Myeloid Cells-1 | 2 | 2011 | 7 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2016 | 121 | 0.080 |
Why?
|
| Ultrasonography | 2 | 2017 | 770 | 0.080 |
Why?
|
| Hearing Loss | 1 | 2014 | 247 | 0.080 |
Why?
|
| Aorta | 2 | 2013 | 430 | 0.080 |
Why?
|
| Nasal Polyps | 1 | 2011 | 59 | 0.080 |
Why?
|
| Mycobacterium avium Complex | 1 | 2011 | 88 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2013 | 198 | 0.080 |
Why?
|
| Beryllium | 2 | 2025 | 161 | 0.080 |
Why?
|
| Antigens, Differentiation | 4 | 2010 | 77 | 0.080 |
Why?
|
| Genomics | 1 | 2016 | 836 | 0.080 |
Why?
|
| Protein Kinases | 2 | 2009 | 315 | 0.080 |
Why?
|
| Mice, Nude | 5 | 2017 | 688 | 0.080 |
Why?
|
| Muscle Development | 2 | 2017 | 116 | 0.080 |
Why?
|
| Growth Hormone | 2 | 1996 | 92 | 0.080 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2011 | 63 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2010 | 43 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 1995 | 412 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 4 | 1999 | 234 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2013 | 233 | 0.080 |
Why?
|
| Alkynes | 1 | 1991 | 66 | 0.080 |
Why?
|
| Papillomaviridae | 2 | 2001 | 115 | 0.080 |
Why?
|
| Phenotype | 4 | 2016 | 3164 | 0.080 |
Why?
|
| Colostrum | 1 | 1990 | 3 | 0.080 |
Why?
|
| Injections, Subcutaneous | 3 | 2017 | 164 | 0.080 |
Why?
|
| Bone Marrow Cells | 7 | 2008 | 320 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2017 | 701 | 0.080 |
Why?
|
| Thromboxanes | 2 | 1988 | 13 | 0.080 |
Why?
|
| Creatine Kinase | 4 | 2001 | 72 | 0.080 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 1048 | 0.080 |
Why?
|
| Rats, Inbred Lew | 5 | 2017 | 103 | 0.080 |
Why?
|
| Mice, Inbred NOD | 3 | 2022 | 610 | 0.080 |
Why?
|
| Microscopy, Confocal | 3 | 2014 | 321 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 157 | 0.080 |
Why?
|
| Respiratory System | 1 | 2011 | 149 | 0.080 |
Why?
|
| Immunoblotting | 6 | 2010 | 300 | 0.080 |
Why?
|
| Comorbidity | 1 | 2015 | 1660 | 0.080 |
Why?
|
| Risk Factors | 8 | 2017 | 10792 | 0.080 |
Why?
|
| Caspase 2 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Eosinophils | 3 | 2004 | 316 | 0.080 |
Why?
|
| Sulfonamides | 2 | 2011 | 581 | 0.080 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 741 | 0.080 |
Why?
|
| Kidney Tubules | 3 | 2008 | 117 | 0.080 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 3 | 1989 | 18 | 0.080 |
Why?
|
| Capillaries | 2 | 1987 | 124 | 0.080 |
Why?
|
| Nerve Growth Factors | 3 | 1995 | 78 | 0.080 |
Why?
|
| Hydrocortisone | 6 | 2015 | 304 | 0.080 |
Why?
|
| Virus Diseases | 3 | 2003 | 216 | 0.080 |
Why?
|
| Sensitivity and Specificity | 5 | 1999 | 1990 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 653 | 0.080 |
Why?
|
| Lymphocyte Culture Test, Mixed | 4 | 2006 | 51 | 0.080 |
Why?
|
| Angiogenic Proteins | 1 | 2009 | 14 | 0.080 |
Why?
|
| Electrophoresis | 2 | 2000 | 31 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2009 | 11 | 0.080 |
Why?
|
| Microspheres | 2 | 2007 | 142 | 0.080 |
Why?
|
| Models, Animal | 2 | 2018 | 392 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 162 | 0.080 |
Why?
|
| Rhinitis | 1 | 2011 | 171 | 0.080 |
Why?
|
| Delivery, Obstetric | 1 | 1990 | 160 | 0.080 |
Why?
|
| Plasmapheresis | 1 | 1989 | 23 | 0.070 |
Why?
|
| Endopeptidases | 2 | 1987 | 82 | 0.070 |
Why?
|
| Lysosomes | 4 | 2006 | 128 | 0.070 |
Why?
|
| Glucagon | 7 | 1996 | 113 | 0.070 |
Why?
|
| Rats, Inbred BN | 1 | 2009 | 55 | 0.070 |
Why?
|
| Pyridines | 5 | 2004 | 605 | 0.070 |
Why?
|
| CD3 Complex | 4 | 2002 | 111 | 0.070 |
Why?
|
| Immunocompetence | 2 | 1987 | 47 | 0.070 |
Why?
|
| Mitogens | 3 | 2006 | 55 | 0.070 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2009 | 36 | 0.070 |
Why?
|
| Acrylonitrile | 1 | 1989 | 2 | 0.070 |
Why?
|
| Thrombomodulin | 1 | 2009 | 15 | 0.070 |
Why?
|
| Ultraviolet Therapy | 1 | 1989 | 17 | 0.070 |
Why?
|
| Transcription Factors | 5 | 2014 | 1742 | 0.070 |
Why?
|
| Complement System Proteins | 2 | 1990 | 316 | 0.070 |
Why?
|
| Macromolecular Substances | 3 | 2004 | 224 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2010 | 219 | 0.070 |
Why?
|
| Peritoneal Cavity | 3 | 1998 | 30 | 0.070 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2009 | 23 | 0.070 |
Why?
|
| Neoplasm Transplantation | 4 | 2017 | 252 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 51 | 0.070 |
Why?
|
| Staphylococcus | 6 | 2003 | 75 | 0.070 |
Why?
|
| Chromatography, Gel | 12 | 1999 | 131 | 0.070 |
Why?
|
| Carcinoma | 1 | 2010 | 228 | 0.070 |
Why?
|
| Dextrans | 1 | 2009 | 86 | 0.070 |
Why?
|
| Immunophenotyping | 3 | 2021 | 322 | 0.070 |
Why?
|
| Sinusitis | 1 | 2011 | 229 | 0.070 |
Why?
|
| Hyperthermia, Induced | 1 | 1990 | 121 | 0.070 |
Why?
|
| Superoxide Dismutase | 3 | 2008 | 301 | 0.070 |
Why?
|
| Phagocytes | 4 | 1984 | 81 | 0.070 |
Why?
|
| Isoelectric Focusing | 7 | 1991 | 30 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1991 | 331 | 0.070 |
Why?
|
| Bone Resorption | 2 | 1996 | 80 | 0.070 |
Why?
|
| Injections | 1 | 2009 | 197 | 0.070 |
Why?
|
| Vitreous Body | 1 | 2009 | 117 | 0.070 |
Why?
|
| Insulin | 15 | 2014 | 2507 | 0.070 |
Why?
|
| Glycerides | 1 | 1988 | 17 | 0.070 |
Why?
|
| Blood Glucose | 9 | 2018 | 2330 | 0.070 |
Why?
|
| RNA | 6 | 2008 | 940 | 0.070 |
Why?
|
| Liposomes | 2 | 2008 | 250 | 0.070 |
Why?
|
| Point Mutation | 3 | 2021 | 243 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 150 | 0.070 |
Why?
|
| Drug Carriers | 2 | 2007 | 130 | 0.070 |
Why?
|
| Neuroglia | 1 | 2009 | 172 | 0.070 |
Why?
|
| Growth Inhibitors | 2 | 1996 | 39 | 0.070 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2008 | 3 | 0.070 |
Why?
|
| Exercise | 3 | 2013 | 2201 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2011 | 251 | 0.070 |
Why?
|
| Diglycerides | 1 | 1988 | 59 | 0.070 |
Why?
|
| Computational Biology | 2 | 2011 | 681 | 0.070 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 3 | 2013 | 108 | 0.070 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2008 | 47 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 194 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2008 | 88 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2013 | 132 | 0.070 |
Why?
|
| Lipoproteins, LDL | 2 | 2016 | 119 | 0.070 |
Why?
|
| Fluorescein Angiography | 1 | 2009 | 189 | 0.070 |
Why?
|
| Ciliary Neurotrophic Factor | 4 | 1996 | 12 | 0.070 |
Why?
|
| Kidney Neoplasms | 3 | 1999 | 412 | 0.070 |
Why?
|
| Cell Survival | 8 | 2012 | 1098 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2016 | 370 | 0.070 |
Why?
|
| Osmotic Pressure | 2 | 1998 | 39 | 0.070 |
Why?
|
| Recurrence | 3 | 2017 | 1135 | 0.070 |
Why?
|
| Pregnancy | 9 | 2000 | 7191 | 0.070 |
Why?
|
| 3T3-L1 Cells | 1 | 2007 | 36 | 0.070 |
Why?
|
| Poly I-C | 2 | 2018 | 57 | 0.070 |
Why?
|
| Platelet Count | 4 | 2018 | 96 | 0.070 |
Why?
|
| Plasminogen Inactivators | 2 | 1987 | 2 | 0.070 |
Why?
|
| Polyglycolic Acid | 1 | 2007 | 44 | 0.070 |
Why?
|
| Prednisone | 1 | 2008 | 221 | 0.070 |
Why?
|
| Anticarcinogenic Agents | 1 | 2008 | 61 | 0.070 |
Why?
|
| Hypothalamus, Anterior | 2 | 1985 | 3 | 0.060 |
Why?
|
| Teichoic Acids | 2 | 2001 | 18 | 0.060 |
Why?
|
| Multiple Sclerosis | 2 | 1990 | 484 | 0.060 |
Why?
|
| Iodine Radioisotopes | 4 | 2013 | 137 | 0.060 |
Why?
|
| Cocarcinogenesis | 1 | 2007 | 13 | 0.060 |
Why?
|
| Antigens, Surface | 5 | 1992 | 157 | 0.060 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2007 | 11 | 0.060 |
Why?
|
| Skin Diseases, Infectious | 1 | 1987 | 13 | 0.060 |
Why?
|
| Flavonoids | 2 | 2004 | 87 | 0.060 |
Why?
|
| Pancreatitis | 1 | 2008 | 145 | 0.060 |
Why?
|
| Etanercept | 2 | 2005 | 60 | 0.060 |
Why?
|
| NF-KappaB Inhibitor alpha | 3 | 2002 | 49 | 0.060 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1986 | 3 | 0.060 |
Why?
|
| Allergens | 2 | 2021 | 384 | 0.060 |
Why?
|
| Parathyroid Hormone | 1 | 1987 | 112 | 0.060 |
Why?
|
| Animals, Newborn | 4 | 2010 | 902 | 0.060 |
Why?
|
| Angina, Unstable | 2 | 2014 | 82 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 1989 | 206 | 0.060 |
Why?
|
| Culture Media, Conditioned | 3 | 2010 | 111 | 0.060 |
Why?
|
| Blood Sedimentation | 2 | 2019 | 37 | 0.060 |
Why?
|
| Remission, Spontaneous | 1 | 2006 | 40 | 0.060 |
Why?
|
| Interferon Regulatory Factor-1 | 5 | 2007 | 17 | 0.060 |
Why?
|
| Cell Degranulation | 1 | 2006 | 42 | 0.060 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2006 | 3 | 0.060 |
Why?
|
| Plasminogen Activators | 1 | 1986 | 7 | 0.060 |
Why?
|
| Isoelectric Point | 6 | 1990 | 23 | 0.060 |
Why?
|
| Fish Oils | 3 | 1998 | 26 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 124 | 0.060 |
Why?
|
| Linkage Disequilibrium | 3 | 2008 | 247 | 0.060 |
Why?
|
| Polyethylene Glycols | 4 | 2006 | 655 | 0.060 |
Why?
|
| Antibody Formation | 3 | 1996 | 294 | 0.060 |
Why?
|
| Arachidonic Acids | 2 | 1984 | 43 | 0.060 |
Why?
|
| Hyperphagia | 1 | 2006 | 38 | 0.060 |
Why?
|
| HMGB1 Protein | 2 | 2017 | 51 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2017 | 365 | 0.060 |
Why?
|
| Hydrolysis | 2 | 2002 | 199 | 0.060 |
Why?
|
| Astrocytoma | 1 | 1987 | 129 | 0.060 |
Why?
|
| Injections, Intraventricular | 4 | 1993 | 58 | 0.060 |
Why?
|
| Stomach Neoplasms | 1 | 2008 | 128 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2022 | 17101 | 0.060 |
Why?
|
| Cyclic AMP | 5 | 1991 | 209 | 0.060 |
Why?
|
| Bacterial Load | 2 | 2017 | 67 | 0.060 |
Why?
|
| Neuroprotective Agents | 2 | 2009 | 143 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2007 | 130 | 0.060 |
Why?
|
| Infant, Newborn | 6 | 1994 | 6434 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 47 | 0.060 |
Why?
|
| Genes, Viral | 1 | 2006 | 90 | 0.060 |
Why?
|
| Coronary Disease | 3 | 1999 | 386 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2012 | 617 | 0.060 |
Why?
|
| Leishmaniasis | 1 | 1985 | 1 | 0.060 |
Why?
|
| Chemokine CCL5 | 2 | 2013 | 41 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 165 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2007 | 302 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 550 | 0.060 |
Why?
|
| Fas Ligand Protein | 2 | 2004 | 60 | 0.060 |
Why?
|
| Osmolar Concentration | 4 | 1998 | 167 | 0.060 |
Why?
|
| Body Fluids | 2 | 2001 | 70 | 0.060 |
Why?
|
| Pancreatic Elastase | 3 | 2015 | 55 | 0.060 |
Why?
|
| CD4 Antigens | 3 | 2005 | 139 | 0.060 |
Why?
|
| Dermatitis | 1 | 2005 | 19 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2008 | 260 | 0.060 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 1997 | 124 | 0.060 |
Why?
|
| Gram-Negative Bacteria | 2 | 2022 | 81 | 0.060 |
Why?
|
| NLR Proteins | 2 | 2017 | 8 | 0.060 |
Why?
|
| Proteolysis | 2 | 2016 | 173 | 0.060 |
Why?
|
| Abscess | 1 | 2006 | 75 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2004 | 157 | 0.060 |
Why?
|
| Antimetabolites | 1 | 1985 | 21 | 0.060 |
Why?
|
| Demography | 2 | 2017 | 288 | 0.060 |
Why?
|
| Dermatitis, Contact | 2 | 2014 | 18 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 769 | 0.060 |
Why?
|
| Receptors, CXCR5 | 1 | 2025 | 27 | 0.060 |
Why?
|
| Clinical Trials as Topic | 5 | 2015 | 1054 | 0.060 |
Why?
|
| Polyethylene Terephthalates | 1 | 2025 | 21 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2013 | 923 | 0.060 |
Why?
|
| Hodgkin Disease | 1 | 1987 | 171 | 0.060 |
Why?
|
| HeLa Cells | 3 | 2017 | 650 | 0.060 |
Why?
|
| Luteal Phase | 1 | 1985 | 46 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2013 | 178 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2010 | 337 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 4 | 1995 | 479 | 0.050 |
Why?
|
| Protein Subunits | 2 | 2003 | 226 | 0.050 |
Why?
|
| Cytoplasm | 5 | 2015 | 269 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2005 | 117 | 0.050 |
Why?
|
| Cycloheximide | 4 | 1990 | 46 | 0.050 |
Why?
|
| Insulin Antagonists | 1 | 1984 | 6 | 0.050 |
Why?
|
| Chemical Phenomena | 4 | 1987 | 81 | 0.050 |
Why?
|
| Receptors, Interferon | 5 | 2008 | 60 | 0.050 |
Why?
|
| Lung Neoplasms | 3 | 2008 | 2642 | 0.050 |
Why?
|
| Infliximab | 1 | 2005 | 108 | 0.050 |
Why?
|
| Precipitin Tests | 2 | 1996 | 93 | 0.050 |
Why?
|
| Oxygen Consumption | 5 | 2014 | 724 | 0.050 |
Why?
|
| Cyclosporins | 1 | 1984 | 71 | 0.050 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2024 | 43 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2004 | 100 | 0.050 |
Why?
|
| Proteoglycans | 4 | 2009 | 110 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 2013 | 100 | 0.050 |
Why?
|
| Dialysis Solutions | 2 | 1998 | 23 | 0.050 |
Why?
|
| Rats, Wistar | 4 | 2012 | 451 | 0.050 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2015 | 65 | 0.050 |
Why?
|
| Epinephrine | 3 | 1993 | 155 | 0.050 |
Why?
|
| Adenosine Diphosphate | 2 | 2015 | 84 | 0.050 |
Why?
|
| Deltaretrovirus Infections | 3 | 1988 | 6 | 0.050 |
Why?
|
| ADP Ribose Transferases | 2 | 2002 | 9 | 0.050 |
Why?
|
| Leukemia | 3 | 2004 | 245 | 0.050 |
Why?
|
| Complement C5 | 3 | 1988 | 33 | 0.050 |
Why?
|
| Catecholamines | 2 | 2010 | 87 | 0.050 |
Why?
|
| Cell Transplantation | 1 | 2003 | 39 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 245 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 331 | 0.050 |
Why?
|
| Bacterial Proteins | 3 | 2022 | 962 | 0.050 |
Why?
|
| Child, Preschool | 10 | 2016 | 11799 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 2004 | 80 | 0.050 |
Why?
|
| Antibody-Producing Cells | 1 | 1983 | 29 | 0.050 |
Why?
|
| Heart Atria | 2 | 2001 | 144 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2011 | 372 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2005 | 201 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 3 | 2011 | 87 | 0.050 |
Why?
|
| Intubation, Intratracheal | 1 | 2006 | 320 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 758 | 0.050 |
Why?
|
| Brain Chemistry | 2 | 1994 | 116 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2016 | 298 | 0.050 |
Why?
|
| Entamoeba histolytica | 1 | 2003 | 10 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2003 | 51 | 0.050 |
Why?
|
| Antigens, Ly | 2 | 2015 | 40 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2010 | 58 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 4 | 2007 | 509 | 0.050 |
Why?
|
| Metalloendopeptidases | 3 | 1995 | 62 | 0.050 |
Why?
|
| Glycosylation | 3 | 1992 | 172 | 0.050 |
Why?
|
| Cyclophosphamide | 3 | 1994 | 266 | 0.050 |
Why?
|
| Cimetidine | 2 | 1994 | 12 | 0.050 |
Why?
|
| Pain | 1 | 1988 | 782 | 0.050 |
Why?
|
| Chemokine CXCL2 | 4 | 2004 | 41 | 0.050 |
Why?
|
| Stimulation, Chemical | 8 | 1989 | 53 | 0.050 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2013 | 20 | 0.050 |
Why?
|
| Wounds and Injuries | 4 | 2000 | 957 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2001 | 76 | 0.050 |
Why?
|
| Models, Molecular | 3 | 2011 | 1619 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 85 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 64 | 0.050 |
Why?
|
| Receptors, Interleukin-9 | 1 | 2022 | 1 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2003 | 392 | 0.050 |
Why?
|
| Matrilin Proteins | 1 | 2022 | 3 | 0.050 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2003 | 70 | 0.050 |
Why?
|
| Fasting | 2 | 1999 | 277 | 0.050 |
Why?
|
| Prognosis | 5 | 2017 | 4293 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 202 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2013 | 74 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2017 | 77 | 0.050 |
Why?
|
| Sleep | 6 | 1989 | 901 | 0.050 |
Why?
|
| Egtazic Acid | 1 | 2002 | 38 | 0.050 |
Why?
|
| Salmonella Infections | 1 | 2003 | 60 | 0.050 |
Why?
|
| Interleukin-11 | 2 | 1999 | 10 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 460 | 0.050 |
Why?
|
| Body Mass Index | 4 | 2016 | 2438 | 0.050 |
Why?
|
| Protozoan Proteins | 1 | 2003 | 93 | 0.050 |
Why?
|
| Virulence | 2 | 2015 | 280 | 0.050 |
Why?
|
| Head Injuries, Closed | 1 | 2002 | 49 | 0.050 |
Why?
|
| Deoxycytidine | 1 | 2023 | 221 | 0.050 |
Why?
|
| Glycopeptides | 2 | 1980 | 44 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2000 | 64 | 0.050 |
Why?
|
| Actins | 3 | 2009 | 425 | 0.040 |
Why?
|
| Megakaryocytes | 2 | 1992 | 34 | 0.040 |
Why?
|
| Genes | 3 | 1987 | 226 | 0.040 |
Why?
|
| Salmonella | 2 | 2001 | 61 | 0.040 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2001 | 8 | 0.040 |
Why?
|
| Chemotaxis | 2 | 2014 | 122 | 0.040 |
Why?
|
| Cross-Linking Reagents | 2 | 1993 | 207 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2008 | 787 | 0.040 |
Why?
|
| Virginia | 2 | 2013 | 55 | 0.040 |
Why?
|
| Longevity | 1 | 2003 | 173 | 0.040 |
Why?
|
| DNA, Recombinant | 3 | 1986 | 48 | 0.040 |
Why?
|
| Depression, Chemical | 2 | 1998 | 16 | 0.040 |
Why?
|
| Caspase 8 | 2 | 2015 | 47 | 0.040 |
Why?
|
| Cholesterol | 3 | 2016 | 408 | 0.040 |
Why?
|
| Mice, Inbred CBA | 3 | 2011 | 57 | 0.040 |
Why?
|
| Calcitriol | 2 | 1993 | 58 | 0.040 |
Why?
|
| Hypoglycemia | 2 | 1998 | 477 | 0.040 |
Why?
|
| Toxoplasma | 1 | 2001 | 49 | 0.040 |
Why?
|
| Uveitis | 2 | 2013 | 148 | 0.040 |
Why?
|
| Microcirculation | 3 | 2003 | 138 | 0.040 |
Why?
|
| Parenteral Nutrition | 2 | 1994 | 105 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 3 | 1990 | 72 | 0.040 |
Why?
|
| Factor Xa | 1 | 2001 | 35 | 0.040 |
Why?
|
| Phosphatidylcholines | 2 | 1995 | 131 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2014 | 427 | 0.040 |
Why?
|
| Cell Cycle | 4 | 1998 | 597 | 0.040 |
Why?
|
| CD56 Antigen | 2 | 2008 | 35 | 0.040 |
Why?
|
| Amino Acids | 6 | 1994 | 522 | 0.040 |
Why?
|
| Colony-Forming Units Assay | 3 | 1990 | 95 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 2011 | 115 | 0.040 |
Why?
|
| Behavior Observation Techniques | 1 | 2020 | 10 | 0.040 |
Why?
|
| Blood Bactericidal Activity | 2 | 1993 | 42 | 0.040 |
Why?
|
| Leukotriene B4 | 2 | 1991 | 37 | 0.040 |
Why?
|
| Blood Specimen Collection | 2 | 1993 | 38 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2020 | 33 | 0.040 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2021 | 60 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2002 | 192 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2020 | 28 | 0.040 |
Why?
|
| Mice, Obese | 3 | 2008 | 66 | 0.040 |
Why?
|
| Chemistry | 3 | 1987 | 41 | 0.040 |
Why?
|
| Creatinine | 3 | 2008 | 506 | 0.040 |
Why?
|
| Cerebral Cortex | 2 | 2020 | 465 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 64 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 293 | 0.040 |
Why?
|
| Systems Biology | 1 | 2021 | 72 | 0.040 |
Why?
|
| Arteritis | 1 | 2000 | 25 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 215 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2001 | 191 | 0.040 |
Why?
|
| CD5 Antigens | 1 | 2000 | 10 | 0.040 |
Why?
|
| Arginine | 2 | 1997 | 262 | 0.040 |
Why?
|
| Hematopoietic Cell Growth Factors | 2 | 1992 | 5 | 0.040 |
Why?
|
| Bacteremia | 2 | 1993 | 221 | 0.040 |
Why?
|
| Coculture Techniques | 3 | 2005 | 246 | 0.040 |
Why?
|
| Linear Models | 2 | 2003 | 854 | 0.040 |
Why?
|
| Prevalence | 2 | 2017 | 2836 | 0.040 |
Why?
|
| Lymphocyte Count | 2 | 2014 | 164 | 0.040 |
Why?
|
| Staphylococcal Infections | 3 | 1994 | 390 | 0.040 |
Why?
|
| Arthritis, Infectious | 1 | 2000 | 72 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2007 | 375 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 3 | 2009 | 418 | 0.040 |
Why?
|
| Half-Life | 2 | 2006 | 151 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2000 | 85 | 0.040 |
Why?
|
| Organ Specificity | 5 | 2003 | 313 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 3 | 1995 | 73 | 0.040 |
Why?
|
| Interleukin-3 | 3 | 1992 | 23 | 0.040 |
Why?
|
| Fibronectins | 2 | 2002 | 136 | 0.040 |
Why?
|
| Peroxidases | 1 | 1999 | 29 | 0.040 |
Why?
|
| Ascitic Fluid | 2 | 1998 | 15 | 0.040 |
Why?
|
| Alkaline Phosphatase | 2 | 2017 | 145 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1996 | 37 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2013 | 109 | 0.040 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 1998 | 35 | 0.040 |
Why?
|
| Ferritins | 1 | 2019 | 69 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1998 | 50 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 1990 | 415 | 0.040 |
Why?
|
| Massachusetts | 3 | 2003 | 180 | 0.040 |
Why?
|
| Biological Transport | 2 | 1998 | 418 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2011 | 38 | 0.040 |
Why?
|
| Granzymes | 1 | 2018 | 49 | 0.040 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2018 | 37 | 0.040 |
Why?
|
| Orthomyxoviridae | 2 | 2016 | 40 | 0.040 |
Why?
|
| Cell Compartmentation | 2 | 1991 | 54 | 0.040 |
Why?
|
| HIV Seropositivity | 2 | 1996 | 119 | 0.040 |
Why?
|
| Uterus | 1 | 2000 | 226 | 0.030 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2000 | 139 | 0.030 |
Why?
|
| 2-Chloroadenosine | 1 | 1998 | 3 | 0.030 |
Why?
|
| Deoxyadenosines | 1 | 1998 | 8 | 0.030 |
Why?
|
| Lymphoid Tissue | 2 | 2013 | 80 | 0.030 |
Why?
|
| Liver X Receptors | 1 | 2018 | 30 | 0.030 |
Why?
|
| THP-1 Cells | 1 | 2018 | 20 | 0.030 |
Why?
|
| Safety | 1 | 2020 | 356 | 0.030 |
Why?
|
| Progesterone | 1 | 2000 | 255 | 0.030 |
Why?
|
| Remission Induction | 1 | 2019 | 308 | 0.030 |
Why?
|
| Oxidants | 1 | 1998 | 103 | 0.030 |
Why?
|
| Connectin | 1 | 2018 | 42 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 75 | 0.030 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 151 | 0.030 |
Why?
|
| Apolipoprotein A-I | 1 | 2018 | 39 | 0.030 |
Why?
|
| Irritants | 1 | 1998 | 38 | 0.030 |
Why?
|
| Dog Diseases | 1 | 1998 | 70 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 309 | 0.030 |
Why?
|
| Exocytosis | 3 | 2006 | 84 | 0.030 |
Why?
|
| Freezing | 2 | 1988 | 86 | 0.030 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 69 | 0.030 |
Why?
|
| fas Receptor | 1 | 1998 | 92 | 0.030 |
Why?
|
| Lipolysis | 3 | 1992 | 46 | 0.030 |
Why?
|
| Methods | 3 | 1987 | 69 | 0.030 |
Why?
|
| Bacteriolysis | 1 | 2017 | 10 | 0.030 |
Why?
|
| Acetates | 2 | 1989 | 80 | 0.030 |
Why?
|
| Lectins | 3 | 1992 | 45 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1998 | 105 | 0.030 |
Why?
|
| Mononuclear Phagocyte System | 4 | 1995 | 10 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2017 | 53 | 0.030 |
Why?
|
| Cell Hypoxia | 2 | 2010 | 247 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1999 | 430 | 0.030 |
Why?
|
| Myosins | 1 | 2018 | 136 | 0.030 |
Why?
|
| Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
|
| Vascular Resistance | 2 | 1989 | 367 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 1997 | 93 | 0.030 |
Why?
|
| Urate Oxidase | 1 | 2017 | 13 | 0.030 |
Why?
|
| Infant | 4 | 2016 | 10039 | 0.030 |
Why?
|
| Lipopeptides | 1 | 2017 | 16 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2017 | 50 | 0.030 |
Why?
|
| E-Selectin | 1 | 1997 | 61 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 520 | 0.030 |
Why?
|
| beta-Defensins | 1 | 2017 | 22 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 170 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 531 | 0.030 |
Why?
|
| Cathelicidins | 1 | 2017 | 41 | 0.030 |
Why?
|
| Age Factors | 4 | 2016 | 3335 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 54 | 0.030 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 39 | 0.030 |
Why?
|
| Hyperuricemia | 1 | 2017 | 47 | 0.030 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2017 | 41 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2009 | 37 | 0.030 |
Why?
|
| Apolipoproteins | 1 | 1997 | 38 | 0.030 |
Why?
|
| Langerhans Cells | 2 | 1989 | 12 | 0.030 |
Why?
|
| Joints | 2 | 2009 | 107 | 0.030 |
Why?
|
| Sex Factors | 3 | 2016 | 2114 | 0.030 |
Why?
|
| Erythrocytes | 3 | 1993 | 757 | 0.030 |
Why?
|
| Cross-Sectional Studies | 5 | 2015 | 5872 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2016 | 55 | 0.030 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1322 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2016 | 16 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 1996 | 15 | 0.030 |
Why?
|
| Weight Lifting | 1 | 1996 | 32 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 336 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 1996 | 54 | 0.030 |
Why?
|
| Laminin | 2 | 2009 | 72 | 0.030 |
Why?
|
| Simian virus 40 | 1 | 1996 | 24 | 0.030 |
Why?
|
| Lymphocyte Subsets | 2 | 2003 | 83 | 0.030 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2017 | 86 | 0.030 |
Why?
|
| Calcimycin | 3 | 1999 | 36 | 0.030 |
Why?
|
| Genetic Markers | 2 | 1995 | 331 | 0.030 |
Why?
|
| Receptors, Interleukin-13 | 1 | 1996 | 2 | 0.030 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 1 | 1996 | 2 | 0.030 |
Why?
|
| Receptors, Interleukin-4 | 1 | 1996 | 16 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 198 | 0.030 |
Why?
|
| RNA Interference | 2 | 2008 | 476 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2016 | 59 | 0.030 |
Why?
|
| Endoscopy | 1 | 1999 | 316 | 0.030 |
Why?
|
| Osteoclasts | 1 | 1996 | 52 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2020 | 710 | 0.030 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 2 | 1988 | 3 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 2003 | 140 | 0.030 |
Why?
|
| Premedication | 3 | 1991 | 42 | 0.030 |
Why?
|
| Sleep Stages | 2 | 1987 | 75 | 0.030 |
Why?
|
| Clone Cells | 4 | 1994 | 266 | 0.030 |
Why?
|
| Complement C3a | 1 | 1996 | 40 | 0.030 |
Why?
|
| Extracorporeal Circulation | 1 | 1996 | 15 | 0.030 |
Why?
|
| Rickettsia | 1 | 1995 | 11 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 2016 | 43 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 242 | 0.030 |
Why?
|
| Biliary Tract Diseases | 1 | 2016 | 33 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 489 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 1998 | 196 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2016 | 514 | 0.030 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 60 | 0.030 |
Why?
|
| APACHE | 1 | 2016 | 66 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 82 | 0.030 |
Why?
|
| Pyrrolidinones | 1 | 1995 | 29 | 0.030 |
Why?
|
| Energy Intake | 2 | 1996 | 500 | 0.030 |
Why?
|
| Feedback | 2 | 1987 | 181 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 481 | 0.030 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 1995 | 15 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1995 | 33 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 2 | 1996 | 726 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2017 | 261 | 0.030 |
Why?
|
| Pulse Wave Analysis | 1 | 2016 | 266 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1986 | 177 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1995 | 90 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 1999 | 338 | 0.030 |
Why?
|
| Rectum | 3 | 1994 | 180 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2015 | 9 | 0.030 |
Why?
|
| Indonesia | 1 | 2015 | 23 | 0.030 |
Why?
|
| Steroids | 1 | 2016 | 160 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2011 | 145 | 0.030 |
Why?
|
| Leptospirosis | 1 | 2015 | 8 | 0.030 |
Why?
|
| Typhoid Fever | 1 | 2015 | 12 | 0.030 |
Why?
|
| Purinergic P2X Receptor Antagonists | 1 | 2015 | 7 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2015 | 11 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2016 | 207 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2015 | 58 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2009 | 392 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 2016 | 124 | 0.030 |
Why?
|
| Culture Techniques | 3 | 1995 | 67 | 0.030 |
Why?
|
| Platelet Function Tests | 1 | 2015 | 34 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 25 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2016 | 162 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2015 | 30 | 0.030 |
Why?
|
| Fixatives | 1 | 1994 | 13 | 0.030 |
Why?
|
| Blast Crisis | 1 | 1995 | 35 | 0.030 |
Why?
|
| Mannose | 1 | 1994 | 23 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 79 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 50 | 0.030 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 1 | 1994 | 1 | 0.030 |
Why?
|
| Plasmids | 1 | 1996 | 379 | 0.030 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2015 | 38 | 0.030 |
Why?
|
| Dinitrofluorobenzene | 1 | 2014 | 4 | 0.030 |
Why?
|
| Incidence | 2 | 2017 | 2883 | 0.030 |
Why?
|
| Herpesviridae Infections | 2 | 1986 | 150 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2015 | 45 | 0.030 |
Why?
|
| Amniotic Fluid | 2 | 1992 | 79 | 0.030 |
Why?
|
| Haptens | 1 | 2014 | 21 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 7 | 0.030 |
Why?
|
| Pyridoxine | 1 | 1995 | 37 | 0.030 |
Why?
|
| Astrocytes | 2 | 2015 | 224 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 49 | 0.030 |
Why?
|
| Biopsy | 3 | 2011 | 1077 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 70 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2014 | 88 | 0.030 |
Why?
|
| Biotransformation | 2 | 1986 | 63 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2014 | 40 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 148 | 0.030 |
Why?
|
| Lactates | 1 | 2014 | 83 | 0.030 |
Why?
|
| Mucus | 2 | 1993 | 73 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 146 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 277 | 0.030 |
Why?
|
| Angiopoietin-like Proteins | 1 | 2014 | 1 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 559 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 75 | 0.030 |
Why?
|
| Inpatients | 1 | 1999 | 546 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2014 | 121 | 0.030 |
Why?
|
| Checklist | 1 | 2015 | 108 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1995 | 159 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2015 | 177 | 0.030 |
Why?
|
| Ranitidine | 1 | 1994 | 14 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2017 | 3676 | 0.030 |
Why?
|
| Calpain | 2 | 2005 | 61 | 0.030 |
Why?
|
| Cytopathogenic Effect, Viral | 2 | 2011 | 16 | 0.030 |
Why?
|
| Common Cold | 1 | 1994 | 15 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 40 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 2118 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2010 | 1495 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1995 | 222 | 0.030 |
Why?
|
| HLA-B51 Antigen | 1 | 2013 | 1 | 0.030 |
Why?
|
| Endostatins | 1 | 2013 | 10 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1994 | 79 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 29 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2014 | 22 | 0.030 |
Why?
|
| Rats, Inbred F344 | 3 | 1989 | 268 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 282 | 0.030 |
Why?
|
| Cattle | 3 | 2003 | 1000 | 0.030 |
Why?
|
| Rhinovirus | 1 | 1994 | 57 | 0.030 |
Why?
|
| Thiazoles | 1 | 1994 | 136 | 0.030 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1993 | 20 | 0.030 |
Why?
|
| Secretory Rate | 3 | 1990 | 12 | 0.030 |
Why?
|
| Seasons | 1 | 2016 | 556 | 0.030 |
Why?
|
| Anilides | 1 | 2014 | 84 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2015 | 310 | 0.030 |
Why?
|
| Amyloid | 2 | 2006 | 92 | 0.030 |
Why?
|
| 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 2 | 1984 | 2 | 0.030 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 2 | 1984 | 3 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 138 | 0.030 |
Why?
|
| Siblings | 1 | 2014 | 195 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 1990 | 28 | 0.030 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 1994 | 35 | 0.030 |
Why?
|
| Myelin Basic Protein | 2 | 1998 | 44 | 0.030 |
Why?
|
| Systole | 1 | 2014 | 178 | 0.030 |
Why?
|
| Critical Care | 1 | 2000 | 697 | 0.020 |
Why?
|
| Feces | 1 | 2017 | 513 | 0.020 |
Why?
|
| Protein Folding | 1 | 2015 | 279 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 2313 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2013 | 54 | 0.020 |
Why?
|
| Isoquinolines | 2 | 1990 | 44 | 0.020 |
Why?
|
| Leukemic Infiltration | 1 | 2013 | 11 | 0.020 |
Why?
|
| NIH 3T3 Cells | 2 | 2003 | 148 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 25 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 1990 | 39 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 1994 | 85 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2013 | 22 | 0.020 |
Why?
|
| Telencephalon | 1 | 1993 | 16 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 175 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 3 | 1989 | 200 | 0.020 |
Why?
|
| Nasal Mucosa | 1 | 1994 | 112 | 0.020 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2013 | 6 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 1991 | 334 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2015 | 278 | 0.020 |
Why?
|
| Immunity, Active | 1 | 2013 | 8 | 0.020 |
Why?
|
| Receptors, Complement | 1 | 1994 | 125 | 0.020 |
Why?
|
| Water | 1 | 1996 | 469 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2013 | 85 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 1993 | 37 | 0.020 |
Why?
|
| Emphysema | 1 | 2014 | 100 | 0.020 |
Why?
|
| Biodiversity | 1 | 2017 | 426 | 0.020 |
Why?
|
| Hyphae | 1 | 2012 | 11 | 0.020 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 197 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1996 | 824 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2015 | 555 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2015 | 230 | 0.020 |
Why?
|
| Anti-Retroviral Agents | 1 | 2015 | 250 | 0.020 |
Why?
|
| Amnion | 2 | 1992 | 28 | 0.020 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1993 | 67 | 0.020 |
Why?
|
| Lipid A | 2 | 1990 | 28 | 0.020 |
Why?
|
| Retroviridae Proteins | 2 | 1989 | 10 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 1095 | 0.020 |
Why?
|
| Hospitals, General | 1 | 1992 | 26 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2012 | 17 | 0.020 |
Why?
|
| Spores, Fungal | 1 | 2012 | 22 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2013 | 134 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 196 | 0.020 |
Why?
|
| Carbohydrate Conformation | 1 | 1992 | 15 | 0.020 |
Why?
|
| Ketone Bodies | 1 | 1992 | 15 | 0.020 |
Why?
|
| Body Surface Area | 1 | 1992 | 35 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2012 | 39 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2013 | 91 | 0.020 |
Why?
|
| Cartilage, Articular | 2 | 2003 | 343 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2015 | 330 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 381 | 0.020 |
Why?
|
| Ureaplasma Infections | 1 | 1992 | 3 | 0.020 |
Why?
|
| Ureaplasma urealyticum | 1 | 1992 | 3 | 0.020 |
Why?
|
| Drug Therapy | 1 | 1993 | 80 | 0.020 |
Why?
|
| Burn Units | 1 | 1992 | 48 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 3415 | 0.020 |
Why?
|
| Calcium Signaling | 2 | 2006 | 252 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2012 | 1465 | 0.020 |
Why?
|
| Fusobacterium Infections | 1 | 1992 | 7 | 0.020 |
Why?
|
| Inhalation Exposure | 1 | 2013 | 115 | 0.020 |
Why?
|
| Cell-Free System | 3 | 2001 | 53 | 0.020 |
Why?
|
| Mycoplasma Infections | 1 | 1992 | 17 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 1996 | 337 | 0.020 |
Why?
|
| Tobacco Products | 1 | 2013 | 84 | 0.020 |
Why?
|
| Haptoglobins | 2 | 1984 | 66 | 0.020 |
Why?
|
| Syndrome | 1 | 1993 | 380 | 0.020 |
Why?
|
| Enteral Nutrition | 1 | 1994 | 216 | 0.020 |
Why?
|
| Paxillin | 1 | 2011 | 11 | 0.020 |
Why?
|
| Bleomycin | 1 | 1973 | 253 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2016 | 370 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1992 | 82 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 1998 | 131 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2016 | 383 | 0.020 |
Why?
|
| Plant Lectins | 1 | 1991 | 8 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 1991 | 25 | 0.020 |
Why?
|
| Soybean Proteins | 1 | 1991 | 14 | 0.020 |
Why?
|
| Retinal Vasculitis | 1 | 2011 | 12 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1992 | 115 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1997 | 809 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2011 | 35 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2017 | 683 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 623 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1695 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1991 | 27 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1991 | 29 | 0.020 |
Why?
|
| Diphenhydramine | 1 | 1991 | 36 | 0.020 |
Why?
|
| Vesicular Stomatitis | 1 | 2011 | 3 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2011 | 6 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 224 | 0.020 |
Why?
|
| Exotoxins | 2 | 2002 | 16 | 0.020 |
Why?
|
| Integrins | 1 | 2011 | 90 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 1992 | 69 | 0.020 |
Why?
|
| P-Selectin | 1 | 2011 | 28 | 0.020 |
Why?
|
| Central Nervous System | 3 | 1997 | 281 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 116 | 0.020 |
Why?
|
| Herpes Genitalis | 1 | 2011 | 17 | 0.020 |
Why?
|
| Vasoconstriction | 3 | 2001 | 217 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2004 | 415 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 373 | 0.020 |
Why?
|
| Nerve Regeneration | 1 | 1991 | 57 | 0.020 |
Why?
|
| Foam Cells | 1 | 2011 | 17 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 1991 | 60 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1325 | 0.020 |
Why?
|
| Ambroxol | 1 | 1990 | 1 | 0.020 |
Why?
|
| Vero Cells | 1 | 2011 | 84 | 0.020 |
Why?
|
| Streptozocin | 1 | 2010 | 21 | 0.020 |
Why?
|
| Basophils | 2 | 1988 | 52 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2016 | 791 | 0.020 |
Why?
|
| Nucleotides, Cyclic | 1 | 1991 | 22 | 0.020 |
Why?
|
| Bucladesine | 1 | 1990 | 19 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2013 | 208 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 497 | 0.020 |
Why?
|
| Staurosporine | 1 | 1990 | 22 | 0.020 |
Why?
|
| Piperazines | 2 | 1990 | 381 | 0.020 |
Why?
|
| Lymphocyte Cooperation | 3 | 1985 | 50 | 0.020 |
Why?
|
| Colforsin | 1 | 1990 | 48 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 3 | 1986 | 160 | 0.020 |
Why?
|
| Nitrites | 1 | 2010 | 89 | 0.020 |
Why?
|
| Cell-Derived Microparticles | 1 | 2011 | 75 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 1991 | 191 | 0.020 |
Why?
|
| Alkaloids | 1 | 1990 | 28 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 826 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 94 | 0.020 |
Why?
|
| HIV-2 | 1 | 1990 | 18 | 0.020 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1990 | 37 | 0.020 |
Why?
|
| Adenylyl Cyclases | 1 | 1990 | 60 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2011 | 175 | 0.020 |
Why?
|
| Calmodulin | 1 | 1990 | 70 | 0.020 |
Why?
|
| Poly A | 2 | 1994 | 50 | 0.020 |
Why?
|
| Cytoplasmic Granules | 2 | 1989 | 74 | 0.020 |
Why?
|
| Trypsin | 2 | 1984 | 76 | 0.020 |
Why?
|
| Serum Albumin | 2 | 1988 | 147 | 0.020 |
Why?
|
| Perfusion | 3 | 2004 | 250 | 0.020 |
Why?
|
| Imidazolines | 1 | 2010 | 3 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 1077 | 0.020 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1990 | 55 | 0.020 |
Why?
|
| Frontal Lobe | 2 | 1990 | 160 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1991 | 132 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2010 | 20 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2011 | 93 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2013 | 353 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 272 | 0.020 |
Why?
|
| Health Status | 1 | 2015 | 836 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 44 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 34 | 0.020 |
Why?
|
| Edema | 1 | 1990 | 124 | 0.020 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 1991 | 138 | 0.020 |
Why?
|
| Clusterin | 1 | 2009 | 11 | 0.020 |
Why?
|
| Histocytochemistry | 2 | 1987 | 79 | 0.020 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1990 | 165 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 109 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2011 | 243 | 0.020 |
Why?
|
| Neisseria meningitidis | 1 | 1989 | 23 | 0.020 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2009 | 49 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2010 | 199 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 369 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 2 | 1994 | 244 | 0.020 |
Why?
|
| Lymphotoxin-alpha | 3 | 1996 | 6 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 2 | 2005 | 760 | 0.020 |
Why?
|
| Arteries | 1 | 1991 | 259 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 1989 | 29 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 312 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 1 | 2013 | 395 | 0.020 |
Why?
|
| Research Design | 1 | 2015 | 1137 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 2004 | 156 | 0.020 |
Why?
|
| Gluconeogenesis | 2 | 2006 | 83 | 0.020 |
Why?
|
| Aprotinin | 1 | 1988 | 11 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2003 | 561 | 0.020 |
Why?
|
| Tetanus Toxoid | 2 | 1986 | 34 | 0.020 |
Why?
|
| Central Venous Pressure | 1 | 1988 | 16 | 0.020 |
Why?
|
| Leucine | 4 | 1996 | 116 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 1995 | 685 | 0.020 |
Why?
|
| Somatostatin | 1 | 1989 | 52 | 0.020 |
Why?
|
| Brain Stem | 1 | 1989 | 96 | 0.020 |
Why?
|
| Mental Health | 1 | 2015 | 792 | 0.020 |
Why?
|
| Ear | 1 | 1988 | 31 | 0.020 |
Why?
|
| Cell Transformation, Viral | 2 | 1986 | 23 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1988 | 74 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2008 | 53 | 0.020 |
Why?
|
| Malaria | 1 | 1989 | 73 | 0.020 |
Why?
|
| Lithostathine | 1 | 2008 | 1 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1988 | 12 | 0.020 |
Why?
|
| Stearic Acids | 1 | 1988 | 16 | 0.020 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1985 | 6 | 0.020 |
Why?
|
| Thyroglobulin | 1 | 1988 | 29 | 0.020 |
Why?
|
| Amylases | 1 | 2008 | 18 | 0.020 |
Why?
|
| Natriuresis | 1 | 1988 | 13 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 1988 | 19 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2011 | 489 | 0.020 |
Why?
|
| Skin Tests | 3 | 1994 | 94 | 0.020 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2008 | 12 | 0.020 |
Why?
|
| Respiratory Burst | 2 | 2002 | 18 | 0.020 |
Why?
|
| Theophylline | 1 | 1988 | 41 | 0.020 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 2 | 1999 | 8 | 0.020 |
Why?
|
| Software | 2 | 2011 | 692 | 0.020 |
Why?
|
| Cytokine Receptor gp130 | 2 | 1999 | 10 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 178 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2010 | 255 | 0.020 |
Why?
|
| Mast Cells | 1 | 2009 | 146 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 405 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1988 | 179 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 966 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2008 | 61 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 1988 | 88 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2007 | 42 | 0.020 |
Why?
|
| Myocardial Depressant Factor | 1 | 2007 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 2010 | 218 | 0.020 |
Why?
|
| Lipase | 1 | 2008 | 75 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2007 | 45 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1977 | 57 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2009 | 200 | 0.020 |
Why?
|
| Microchemistry | 1 | 1987 | 19 | 0.020 |
Why?
|
| Adrenal Cortex | 1 | 1987 | 33 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1990 | 284 | 0.020 |
Why?
|
| Bile | 1 | 1987 | 26 | 0.020 |
Why?
|
| Protein Deficiency | 1 | 1987 | 4 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1989 | 501 | 0.020 |
Why?
|
| Reference Standards | 1 | 1988 | 178 | 0.020 |
Why?
|
| Denmark | 2 | 2000 | 50 | 0.020 |
Why?
|
| Cytotoxins | 1 | 1987 | 16 | 0.020 |
Why?
|
| Proinsulin | 1 | 1987 | 51 | 0.020 |
Why?
|
| Hyperbaric Oxygenation | 1 | 1987 | 39 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1987 | 30 | 0.020 |
Why?
|
| Vacuoles | 1 | 1987 | 38 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 109 | 0.020 |
Why?
|
| Receptors, Angiotensin | 1 | 1987 | 11 | 0.020 |
Why?
|
| Cysteine | 1 | 2008 | 210 | 0.020 |
Why?
|
| Angiotensinogen | 1 | 2006 | 4 | 0.020 |
Why?
|
| 7-Alkoxycoumarin O-Dealkylase | 1 | 1986 | 1 | 0.020 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1987 | 13 | 0.020 |
Why?
|
| Kidney Cortex | 1 | 2006 | 27 | 0.020 |
Why?
|
| Oxygenases | 1 | 1986 | 13 | 0.020 |
Why?
|
| Leukopenia | 1 | 1987 | 33 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1987 | 44 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 142 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 1986 | 28 | 0.020 |
Why?
|
| Cytochalasin B | 2 | 1984 | 8 | 0.020 |
Why?
|
| Echocardiography | 1 | 2010 | 652 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2006 | 28 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2010 | 375 | 0.020 |
Why?
|
| Phospholipids | 1 | 1988 | 213 | 0.020 |
Why?
|
| Drug Compounding | 1 | 2007 | 107 | 0.020 |
Why?
|
| Hepatitis, Alcoholic | 1 | 1986 | 16 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1987 | 151 | 0.020 |
Why?
|
| Newcastle disease virus | 1 | 1986 | 18 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2007 | 284 | 0.020 |
Why?
|
| Ureter | 1 | 2006 | 36 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2007 | 183 | 0.020 |
Why?
|
| Phospholipases | 1 | 2006 | 14 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1986 | 24 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2006 | 52 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 2 | 2003 | 178 | 0.020 |
Why?
|
| Carcinogens | 1 | 2007 | 123 | 0.020 |
Why?
|
| HIV | 1 | 1987 | 250 | 0.010 |
Why?
|
| Peptide Hydrolases | 2 | 1984 | 105 | 0.010 |
Why?
|
| Vasculitis | 1 | 1986 | 69 | 0.010 |
Why?
|
| K562 Cells | 1 | 2006 | 93 | 0.010 |
Why?
|
| Genome, Human | 1 | 2008 | 422 | 0.010 |
Why?
|
| Chromatography | 1 | 1986 | 27 | 0.010 |
Why?
|
| Receptors, Adiponectin | 1 | 2006 | 22 | 0.010 |
Why?
|
| Chemical Precipitation | 2 | 1977 | 39 | 0.010 |
Why?
|
| Fibrinogen | 2 | 1984 | 177 | 0.010 |
Why?
|
| Consensus Sequence | 2 | 1996 | 74 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2006 | 147 | 0.010 |
Why?
|
| Cyclic GMP | 2 | 1999 | 92 | 0.010 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2005 | 15 | 0.010 |
Why?
|
| Histamine Release | 1 | 1985 | 10 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1986 | 162 | 0.010 |
Why?
|
| Hybridomas | 2 | 2001 | 234 | 0.010 |
Why?
|
| Organ Culture Techniques | 3 | 1991 | 154 | 0.010 |
Why?
|
| Leishmania | 1 | 1985 | 3 | 0.010 |
Why?
|
| Receptors, Opioid | 1 | 1985 | 23 | 0.010 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2005 | 12 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2005 | 23 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 1992 | 158 | 0.010 |
Why?
|
| Potassium | 1 | 2006 | 152 | 0.010 |
Why?
|
| Antigens, Protozoan | 1 | 1985 | 32 | 0.010 |
Why?
|
| Human papillomavirus 16 | 1 | 2005 | 27 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 2005 | 72 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1986 | 229 | 0.010 |
Why?
|
| United States | 2 | 2011 | 15988 | 0.010 |
Why?
|
| Puromycin | 1 | 1985 | 10 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2005 | 65 | 0.010 |
Why?
|
| Epitopes | 2 | 1985 | 485 | 0.010 |
Why?
|
| Leukemia P388 | 1 | 1985 | 7 | 0.010 |
Why?
|
| Follicular Phase | 1 | 1985 | 38 | 0.010 |
Why?
|
| Phorbols | 1 | 1985 | 10 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 1987 | 176 | 0.010 |
Why?
|
| Ovulation | 1 | 1985 | 41 | 0.010 |
Why?
|
| Lipodystrophy | 1 | 2005 | 14 | 0.010 |
Why?
|
| Physical Endurance | 1 | 1986 | 278 | 0.010 |
Why?
|
| Antitoxins | 1 | 1984 | 1 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1984 | 53 | 0.010 |
Why?
|
| Leukocytosis | 1 | 2005 | 32 | 0.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2005 | 55 | 0.010 |
Why?
|
| Reticulocytes | 1 | 1984 | 17 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 1985 | 27 | 0.010 |
Why?
|
| DNA Probes | 1 | 2004 | 59 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2004 | 55 | 0.010 |
Why?
|
| Zea mays | 1 | 2005 | 43 | 0.010 |
Why?
|
| Macrophage-Activating Factors | 1 | 1984 | 3 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 4 | 1986 | 176 | 0.010 |
Why?
|
| Nutritional Status | 2 | 1998 | 354 | 0.010 |
Why?
|
| Leukocyte Migration-Inhibitory Factors | 1 | 1984 | 1 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1987 | 315 | 0.010 |
Why?
|
| Edetic Acid | 2 | 1995 | 47 | 0.010 |
Why?
|
| Absorption | 1 | 1984 | 60 | 0.010 |
Why?
|
| Arginase | 1 | 1984 | 27 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2738 | 0.010 |
Why?
|
| Ovum | 1 | 1984 | 31 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 1985 | 112 | 0.010 |
Why?
|
| Circadian Rhythm | 3 | 1997 | 514 | 0.010 |
Why?
|
| Oxidants, Photochemical | 1 | 2004 | 8 | 0.010 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2004 | 14 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 1984 | 46 | 0.010 |
Why?
|
| Sclerosis | 1 | 1984 | 11 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1984 | 82 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1984 | 39 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2004 | 50 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 241 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1990 | 970 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1984 | 101 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 2 | 1994 | 29 | 0.010 |
Why?
|
| Peritoneum | 1 | 1984 | 45 | 0.010 |
Why?
|
| Thrombosis | 1 | 1987 | 393 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2003 | 59 | 0.010 |
Why?
|
| Cations | 1 | 1984 | 82 | 0.010 |
Why?
|
| Pokeweed Mitogens | 1 | 1983 | 7 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1983 | 41 | 0.010 |
Why?
|
| Microtubules | 1 | 2006 | 286 | 0.010 |
Why?
|
| Oxygen | 1 | 1989 | 995 | 0.010 |
Why?
|
| Lupus Nephritis | 1 | 2003 | 70 | 0.010 |
Why?
|
| Epidermis | 1 | 1984 | 157 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2003 | 111 | 0.010 |
Why?
|
| Anemia | 1 | 1984 | 188 | 0.010 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2003 | 34 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 3 | 1988 | 37 | 0.010 |
Why?
|
| Nitrogen | 3 | 1989 | 170 | 0.010 |
Why?
|
| Electroencephalography | 4 | 1987 | 551 | 0.010 |
Why?
|
| Respiration | 3 | 1988 | 207 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 2002 | 18 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 750 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 6053 | 0.010 |
Why?
|
| Virus Physiological Phenomena | 1 | 1982 | 8 | 0.010 |
Why?
|
| Cortisone | 1 | 1982 | 16 | 0.010 |
Why?
|
| Glioma | 1 | 1987 | 426 | 0.010 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2002 | 17 | 0.010 |
Why?
|
| Sonication | 1 | 2002 | 12 | 0.010 |
Why?
|
| Carboxypeptidase B | 1 | 1982 | 1 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 2002 | 33 | 0.010 |
Why?
|
| Carboxypeptidases | 1 | 1982 | 12 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 92 | 0.010 |
Why?
|
| Halogens | 1 | 1982 | 14 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 1137 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2002 | 73 | 0.010 |
Why?
|
| Drug Evaluation | 2 | 1988 | 79 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 1980 | 0.010 |
Why?
|
| Hyaluronan Receptors | 1 | 2002 | 102 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1982 | 106 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2002 | 69 | 0.010 |
Why?
|
| Isoxazoles | 1 | 1982 | 54 | 0.010 |
Why?
|
| Vitamin E | 2 | 1993 | 121 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2001 | 47 | 0.010 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 1982 | 60 | 0.010 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2001 | 11 | 0.010 |
Why?
|
| Hypertension, Renal | 1 | 2001 | 15 | 0.010 |
Why?
|
| Tuberculin | 2 | 1994 | 8 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1981 | 77 | 0.010 |
Why?
|
| Guinea Pigs | 3 | 1987 | 159 | 0.010 |
Why?
|
| Ileum | 1 | 2002 | 111 | 0.010 |
Why?
|
| Tyrosine | 1 | 1982 | 222 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 1472 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2001 | 100 | 0.010 |
Why?
|
| Temperature | 2 | 1996 | 679 | 0.010 |
Why?
|
| Mortality | 1 | 2003 | 376 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1984 | 668 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2000 | 8 | 0.010 |
Why?
|
| Albumins | 1 | 1981 | 118 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 2947 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 2002 | 208 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2003 | 378 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1990 | 40 | 0.010 |
Why?
|
| Ionophores | 1 | 1999 | 21 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 419 | 0.010 |
Why?
|
| Tuftsin | 1 | 1979 | 4 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 1979 | 14 | 0.010 |
Why?
|
| HLA-DR4 Antigen | 1 | 2000 | 74 | 0.010 |
Why?
|
| HLA-DR3 Antigen | 1 | 2000 | 76 | 0.010 |
Why?
|
| Tritium | 2 | 1990 | 68 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1999 | 72 | 0.010 |
Why?
|
| Immunologic Techniques | 2 | 1990 | 38 | 0.010 |
Why?
|
| Ceramidases | 1 | 1999 | 4 | 0.010 |
Why?
|
| Neurons | 3 | 1995 | 1642 | 0.010 |
Why?
|
| Zinc | 3 | 1987 | 295 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 1995 | 192 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1981 | 224 | 0.010 |
Why?
|
| Amidohydrolases | 1 | 1999 | 32 | 0.010 |
Why?
|
| Glycerol | 2 | 1991 | 90 | 0.010 |
Why?
|
| Sphingosine | 1 | 1999 | 45 | 0.010 |
Why?
|
| Poxviridae | 1 | 1999 | 3 | 0.010 |
Why?
|
| Coronary Care Units | 1 | 1999 | 26 | 0.010 |
Why?
|
| Myocardial Reperfusion | 1 | 1999 | 59 | 0.010 |
Why?
|
| Receptors, Leptin | 1 | 1999 | 25 | 0.010 |
Why?
|
| Orosomucoid | 2 | 1993 | 9 | 0.010 |
Why?
|
| Troponin T | 1 | 1999 | 65 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1999 | 206 | 0.010 |
Why?
|
| Glucuronidase | 2 | 1989 | 25 | 0.010 |
Why?
|
| Heterozygote | 1 | 2000 | 315 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1998 | 32 | 0.010 |
Why?
|
| Body Water | 1 | 1998 | 23 | 0.010 |
Why?
|
| Chondrocytes | 1 | 2000 | 232 | 0.010 |
Why?
|
| Colorado | 1 | 2008 | 4564 | 0.010 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 1998 | 35 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1998 | 65 | 0.010 |
Why?
|
| Diet | 2 | 1997 | 1275 | 0.010 |
Why?
|
| Portacaval Shunt, Surgical | 2 | 1989 | 2 | 0.010 |
Why?
|
| Drug Interactions | 2 | 1989 | 401 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1977 | 18 | 0.010 |
Why?
|
| Thymidine | 2 | 1990 | 60 | 0.010 |
Why?
|
| Introns | 1 | 1999 | 254 | 0.010 |
Why?
|
| Epithelium | 2 | 1990 | 314 | 0.010 |
Why?
|
| Meningitis, Meningococcal | 1 | 1997 | 6 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1999 | 331 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1998 | 76 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 1998 | 68 | 0.010 |
Why?
|
| Phentolamine | 1 | 1997 | 20 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3869 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1977 | 130 | 0.010 |
Why?
|
| Dogs | 1 | 1998 | 438 | 0.010 |
Why?
|
| Receptors, Adrenergic | 1 | 1997 | 20 | 0.010 |
Why?
|
| Hand | 1 | 1998 | 161 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1978 | 178 | 0.010 |
Why?
|
| Copper | 2 | 1987 | 113 | 0.010 |
Why?
|
| Skin Window Technique | 1 | 1976 | 2 | 0.010 |
Why?
|
| Granuloma | 2 | 1989 | 96 | 0.010 |
Why?
|
| Forecasting | 1 | 1998 | 391 | 0.010 |
Why?
|
| Democratic Republic of the Congo | 1 | 1996 | 33 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1996 | 6 | 0.010 |
Why?
|
| Oncostatin M | 1 | 1996 | 6 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1998 | 221 | 0.010 |
Why?
|
| Antibody Specificity | 2 | 1988 | 181 | 0.010 |
Why?
|
| Blood Donors | 1 | 1998 | 143 | 0.010 |
Why?
|
| Epoprostenol | 2 | 1987 | 131 | 0.010 |
Why?
|
| Viral Proteins | 1 | 1999 | 355 | 0.010 |
Why?
|
| Etiocholanolone | 2 | 1986 | 6 | 0.010 |
Why?
|
| Rolipram | 1 | 1995 | 4 | 0.010 |
Why?
|
| Radiography | 1 | 1998 | 845 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2003 | 1504 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 1995 | 23 | 0.010 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 1995 | 9 | 0.010 |
Why?
|
| Captopril | 1 | 1995 | 11 | 0.010 |
Why?
|
| Phenol | 1 | 1995 | 18 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 931 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 1995 | 28 | 0.010 |
Why?
|
| Macaca | 1 | 1975 | 65 | 0.010 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1995 | 5 | 0.010 |
Why?
|
| Bilirubin | 1 | 1995 | 97 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1995 | 273 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 433 | 0.010 |
Why?
|
| Interphase | 2 | 1985 | 38 | 0.010 |
Why?
|
| Pyridoxal Phosphate | 1 | 1995 | 25 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1995 | 132 | 0.010 |
Why?
|
| Tablets | 1 | 1974 | 41 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1975 | 191 | 0.010 |
Why?
|
| Smoke Inhalation Injury | 1 | 1995 | 30 | 0.010 |
Why?
|
| Food, Formulated | 1 | 1994 | 16 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 1996 | 165 | 0.010 |
Why?
|
| Dialysis | 1 | 1974 | 18 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1974 | 25 | 0.010 |
Why?
|
| Iron | 2 | 1987 | 359 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 1994 | 29 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1996 | 198 | 0.010 |
Why?
|
| Menstruation | 1 | 1994 | 42 | 0.010 |
Why?
|
| Antigens, Dermatophagoides | 1 | 1994 | 10 | 0.010 |
Why?
|
| Hypertension | 1 | 2003 | 1264 | 0.010 |
Why?
|
| Streptokinase | 1 | 1994 | 9 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1994 | 28 | 0.010 |
Why?
|
| Mites | 1 | 1994 | 8 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 1995 | 127 | 0.010 |
Why?
|
| Shwartzman Phenomenon | 1 | 1973 | 1 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1994 | 18 | 0.010 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1994 | 40 | 0.010 |
Why?
|
| Octoxynol | 1 | 1993 | 13 | 0.010 |
Why?
|
| Phagocyte Bactericidal Dysfunction | 1 | 1973 | 11 | 0.010 |
Why?
|
| Lung Abscess | 1 | 1973 | 7 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1996 | 494 | 0.010 |
Why?
|
| Detergents | 1 | 1993 | 44 | 0.010 |
Why?
|
| Nocardia Infections | 1 | 1973 | 11 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1994 | 319 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1996 | 384 | 0.010 |
Why?
|
| Genomic Library | 1 | 1993 | 17 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 85 | 0.010 |
Why?
|
| Folic Acid | 1 | 1995 | 199 | 0.010 |
Why?
|
| Base Composition | 1 | 1993 | 82 | 0.010 |
Why?
|
| Weight Gain | 1 | 1997 | 559 | 0.010 |
Why?
|
| Chorion | 1 | 1992 | 5 | 0.010 |
Why?
|
| DNA Replication | 2 | 1986 | 251 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 141 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1994 | 225 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 1995 | 600 | 0.010 |
Why?
|
| Prostaglandin Antagonists | 1 | 1992 | 3 | 0.010 |
Why?
|
| Papio | 1 | 1992 | 85 | 0.010 |
Why?
|
| Age of Onset | 1 | 1994 | 551 | 0.010 |
Why?
|
| Tibia | 1 | 1973 | 176 | 0.010 |
Why?
|
| Polyvinyls | 1 | 1991 | 20 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1995 | 688 | 0.010 |
Why?
|
| Chylomicrons | 1 | 1991 | 19 | 0.010 |
Why?
|
| Muscimol | 1 | 1991 | 23 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1973 | 143 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 1992 | 116 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1991 | 32 | 0.010 |
Why?
|
| Drug Implants | 1 | 1991 | 83 | 0.010 |
Why?
|
| Pollen | 1 | 1990 | 19 | 0.010 |
Why?
|
| Prostaglandin D2 | 1 | 1990 | 22 | 0.010 |
Why?
|
| RNA Probes | 1 | 1990 | 12 | 0.010 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 1990 | 32 | 0.010 |
Why?
|
| Acyl Coenzyme A | 1 | 1990 | 32 | 0.010 |
Why?
|
| Citrates | 1 | 1990 | 41 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1994 | 1540 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 1990 | 76 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1991 | 166 | 0.000 |
Why?
|
| Citric Acid | 1 | 1990 | 34 | 0.000 |
Why?
|
| Carbohydrate Sequence | 1 | 1990 | 28 | 0.000 |
Why?
|
| Receptors, Fc | 1 | 1990 | 55 | 0.000 |
Why?
|
| Chlorides | 1 | 1991 | 142 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 187 | 0.000 |
Why?
|
| Bradykinin | 1 | 1989 | 48 | 0.000 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1989 | 3 | 0.000 |
Why?
|
| HIV Antigens | 1 | 1989 | 17 | 0.000 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1989 | 35 | 0.000 |
Why?
|
| Arylsulfatases | 1 | 1989 | 1 | 0.000 |
Why?
|
| Plasmodium falciparum | 1 | 1989 | 39 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1993 | 405 | 0.000 |
Why?
|
| Thymoma | 1 | 1989 | 36 | 0.000 |
Why?
|
| Acinetobacter | 1 | 1989 | 16 | 0.000 |
Why?
|
| Peanut Agglutinin | 1 | 1989 | 1 | 0.000 |
Why?
|
| Serum Albumin, Bovine | 1 | 1989 | 62 | 0.000 |
Why?
|
| Glutathione Reductase | 1 | 1989 | 25 | 0.000 |
Why?
|
| Diencephalon | 1 | 1989 | 14 | 0.000 |
Why?
|
| Glutathione Peroxidase | 1 | 1989 | 39 | 0.000 |
Why?
|
| Carbon Radioisotopes | 1 | 1988 | 29 | 0.000 |
Why?
|
| Pulse | 1 | 1988 | 27 | 0.000 |
Why?
|
| Oligosaccharides | 1 | 1989 | 60 | 0.000 |
Why?
|
| Antigens, CD1 | 1 | 1989 | 60 | 0.000 |
Why?
|
| Catalase | 1 | 1989 | 130 | 0.000 |
Why?
|
| Hospitalization | 1 | 1999 | 2434 | 0.000 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1988 | 51 | 0.000 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1989 | 69 | 0.000 |
Why?
|
| Pituitary Hormones | 1 | 1988 | 15 | 0.000 |
Why?
|
| Thorium Dioxide | 1 | 1968 | 1 | 0.000 |
Why?
|
| Consciousness | 1 | 1988 | 34 | 0.000 |
Why?
|
| Prostaglandins H | 1 | 1987 | 1 | 0.000 |
Why?
|
| Prostaglandin H2 | 1 | 1987 | 1 | 0.000 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1987 | 2 | 0.000 |
Why?
|
| Alprostadil | 1 | 1988 | 29 | 0.000 |
Why?
|
| Thyrotropin | 1 | 1988 | 118 | 0.000 |
Why?
|
| Aldosterone | 1 | 1987 | 43 | 0.000 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1988 | 119 | 0.000 |
Why?
|
| Genes, Homeobox | 1 | 1987 | 50 | 0.000 |
Why?
|
| Neurotransmitter Agents | 1 | 1988 | 82 | 0.000 |
Why?
|
| Biliary Fistula | 1 | 1987 | 4 | 0.000 |
Why?
|
| Haplorhini | 2 | 1979 | 52 | 0.000 |
Why?
|
| Intracellular Fluid | 1 | 1987 | 25 | 0.000 |
Why?
|
| Deltaretrovirus | 1 | 1987 | 12 | 0.000 |
Why?
|
| Acetic Acid | 1 | 1987 | 21 | 0.000 |
Why?
|
| Methylhistidines | 1 | 1986 | 1 | 0.000 |
Why?
|
| Receptors, Vasopressin | 1 | 1987 | 20 | 0.000 |
Why?
|
| Synapses | 1 | 1991 | 439 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1988 | 242 | 0.000 |
Why?
|
| Erythropoiesis | 1 | 1987 | 57 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1988 | 315 | 0.000 |
Why?
|
| Complement Factor B | 1 | 1987 | 106 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1986 | 7 | 0.000 |
Why?
|
| Placenta | 1 | 1993 | 780 | 0.000 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1986 | 92 | 0.000 |
Why?
|
| Bile Acids and Salts | 1 | 1987 | 164 | 0.000 |
Why?
|
| Splenectomy | 1 | 1986 | 65 | 0.000 |
Why?
|
| Erythropoietin | 1 | 1987 | 100 | 0.000 |
Why?
|
| Sleep, REM | 1 | 1986 | 44 | 0.000 |
Why?
|
| Sepharose | 1 | 1985 | 32 | 0.000 |
Why?
|
| Hematologic Tests | 1 | 1985 | 21 | 0.000 |
Why?
|
| Forearm | 1 | 1986 | 140 | 0.000 |
Why?
|
| Fishes | 1 | 1986 | 108 | 0.000 |
Why?
|
| Swine | 1 | 1988 | 833 | 0.000 |
Why?
|
| Urine | 1 | 1985 | 62 | 0.000 |
Why?
|
| Alanine | 1 | 1986 | 171 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1987 | 598 | 0.000 |
Why?
|
| Conalbumin | 1 | 1984 | 3 | 0.000 |
Why?
|
| Mice, Inbred AKR | 1 | 1984 | 37 | 0.000 |
Why?
|
| Immunoelectrophoresis | 1 | 1984 | 13 | 0.000 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1985 | 196 | 0.000 |
Why?
|
| Anisomycin | 1 | 1984 | 7 | 0.000 |
Why?
|
| Movement | 1 | 1987 | 294 | 0.000 |
Why?
|
| Salmonella enteritidis | 1 | 1983 | 17 | 0.000 |
Why?
|
| Schistosomiasis | 1 | 1984 | 49 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1983 | 85 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 1958 | 0.000 |
Why?
|
| Hypoxia | 1 | 1991 | 1199 | 0.000 |
Why?
|
| Narcotic Antagonists | 1 | 1985 | 206 | 0.000 |
Why?
|
| Mitomycins | 1 | 1982 | 6 | 0.000 |
Why?
|
| Esterases | 1 | 1982 | 9 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 672 | 0.000 |
Why?
|
| Ultraviolet Rays | 1 | 1984 | 388 | 0.000 |
Why?
|
| Hormones | 1 | 1981 | 134 | 0.000 |
Why?
|
| Listeriosis | 1 | 1980 | 65 | 0.000 |
Why?
|
| Nitroblue Tetrazolium | 1 | 1979 | 12 | 0.000 |
Why?
|
| Hemocyanins | 1 | 1979 | 61 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1984 | 642 | 0.000 |
Why?
|
| Cations, Divalent | 1 | 1978 | 47 | 0.000 |
Why?
|
| Lactoferrin | 1 | 1978 | 36 | 0.000 |
Why?
|
| Naproxen | 1 | 1978 | 21 | 0.000 |
Why?
|
| Muramidase | 1 | 1978 | 67 | 0.000 |
Why?
|
| Acetaminophen | 1 | 1979 | 264 | 0.000 |
Why?
|
| Sodium Salicylate | 1 | 1975 | 1 | 0.000 |
Why?
|
| Dura Mater | 1 | 1975 | 35 | 0.000 |
Why?
|
| Maryland | 1 | 1974 | 66 | 0.000 |
Why?
|
| Sulfadiazine | 1 | 1973 | 6 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1973 | 175 | 0.000 |
Why?
|